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Lipids are essential components to all known life. They serve m any functions from basic building blocks to covalent protein modification and are particularly involved in signaling. Many rare
and widespread human health concerns involve lipids but despite their importance, their analysis
either free or protein-bound has rem ained difficult for decades. Here, us ing bioorthogonal chemistry, we have developed a robust system

to identify the proteins m odified by lipids and ad-

vanced the ability to image cholesterol in cells and tissues.

The unbiased proteom ic analysis of fatty-acylate d proteins using chem ical reporters undertaken
here revealed a greater diversity of lipid-m odified proteins in mammalian cells than had pr eviously been appreciated. Proteins targeted by a series of fatty acid ch emical reporters rangin g
from myristic to stearic acid s howed their involvement in a vast range of cellular processes from
all cellular com partments. Many nuclear proteins we re found, in particular histone H 3 variants.
Histones H3.1, H3.2 and H3.3 were demonstrated to be modified with fatty acid chemical reporters on the conserved cysteine 110, a novel site of S-acylation on histone H3.2. This newly discovered modification of histone H3 variants could have implications for nuclear organization and
chromatin regulation.

Cholesterol is an abundan t sterol in the m embranes of higher eukaryotes that is important in
mammalian physio logy and d isease. This ancient lipid serves m ultiple ess ential functions in
membranes and signaling, but the precise m echanisms of its trafficking and function as a protein
PTM remain to be f ully elucidated. The m ultiple techniques developed to visua lize cholesterol
often give conflicting results and can inaccurately depict cholesterol distribution due to structural
perturbations of analogs or stai ning specificities. Here, using cl ick chemistry, we developed the
fluorescent visualization of c holesterol protein modification and cholesterol trafficking in vivo
with 25-azidonorcholesterol (az-chol). Az-chol exhibits m inimal structural perturbation, is covalently attached to proteins, incorporates into membranes like cholesterol, faithfully detects alterations in lipid trafficking and reveals an asymm etrical cholesterol distribution in the brain of the
developing mouse em bryo. The bioorthogonal chem ical reporter az-chol provides a new, sensitive and versatile too l to investigate choles terol distribution from individual proteins to whole
organisms.

Lovingly dedicated to my family, generations after and generations before.
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INTRODUCTION: LIPIDS AND THEIR STUDY
Lipids are essential components of all cells that are unique in their ability to self-assemble, organizing through membrane segregation. They are also unique in their heterogeneity: the lipidome of yeast exhibits several hundred species1 and hundreds of thousands of variant exist within biology1. Matching their biological importance, lipid binding domains are among the most
common modular domains of the eukaryotic proteome2. In health, alterations of lipid metabolism
can lead to diseases as common as cardiovascular disease and obesity, as well as rarer disorders
such as Niemann-Pick or Tay-Sachs Diseases. Despite this importance, lipid analysis remains
challenging and progress in analytical techniques is greatly needed.

Lipid function

Free lipids
Lipids and their derivatives function in a vast array of cellular functions. In membranes, they are
the primary building block, with different membranes exhibiting remarkable compositional variation. Localized membrane domains are important in signaling and other processes such as catabolism and photosynthesis. In metabolism, lipids serve not only as energy storage but also as
essential vitamins for many organisms. Some, like the eicosanoids (leukotrienes and prostaglandins)3 and diacylglycerols are signaling molecules, while others such as sterols serve multiple
roles as signaling molecules, nutrient and membrane components. Lipids play a role in all cellular processes from the cell boundary to the catalytic center of some enzymes.

1

Covalently protein-bound lipids
Lipids are a covalent post-translational modification (PTM) on proteins where they serve to
modulate protein localization, activity and signaling. This occurs for a variety of lipids (see Figure 1) including fatty acids (caprylic4, myristic, palmitic and stearic acids and others) on their Ntermini, cysteines, serines, threonines or lysines; isoprenoids (farnesol and geranylgeraniol and
dolichol) on cysteines; and cholesterol and glycosylphosphatidylinositol on processed C-termini.
These post-translational modifications (PTMs) play important roles in eukaryotic physiology and
human disease5. Lipid modification of proteins typically increases their affinity to membranes
and subsequent interaction with other proteins for cell signaling5,6 (Figure 2). Biologically,
known fatty-acylated proteins have wide-ranging roles in cellular proliferation (Ras), lymphocyte activation (Lck) and synaptic transmission (PSD-95)5, among many others. N-myristoylation and S-palmitoylation in particular compromise two major mechanisms of protein lipidation by which eukaryotic cells control protein activity spatially and temporally5. Partially due to
prior limitations in analytical techniques, much remains to be understood about the diversity of
lipidated proteins and the mechanisms of their regulation5. This research is further complicated
by the actions of other PTMs which simultaneous affect the activity of lipid modified proteins.
For example, phosphorylation and fatty-acylation work in concert to regulate the activity of
MARCKS7, c-Abl kinase8,9 and potassium channels10.

2

Figure 1 Covalent lipid modifications and their structure.

3

Figure 2 Cellular pathways involving lipid PTMs.

N-Myristoylation is a constitutive cotranslational modification in which myristic acid (14:0) is
attached to N-terminal glycine residues through the action of N-myristoyltransferases (NMTs)11.
It can also occur post-translationally after proteolytic events which expose new NMT recognition
sites. For example, during programmed cell death, the apoptosis effector tBid is N-myristoylated
after cleavage by caspase-3, resulting in mitochondrial membranes localization during apoptosis12,13. Alternative splicing of mRNA transcripts may also yield substrates for N-myristoylation,
as with the p35 isoform of OCA-B, a transcription factor required for late-stage B cell development14,15.

4

Palmitoylation denotes the addition of palmitic (16:0) and other fatty acids onto proteins, most
commonly onto a cysteine thiol side chain (S-acylation) although other residues including the Nterminus can be modified16,17. The terms “palmitoylation” and S-acylation are commonly used
interchangeably to indicate modification not exclusive to palmitic acid. The modification is biased to palmitic acid but includes a heterogeneous mix of fatty acids both longer and shorter
which can also vary in degree of saturation and oxidation. Stearate (18:0), oleate (18:1), arachidonate (20:4), and eicosapentaenoate (20:5) have all been shown to be incorporated onto palmitoylated proteins18,19. The thioester bond of S-acylation can be cleaved by hydroxyl amine; this
sensitivity is often used to distinguish fatty acylation of cysteine from N-terminal modification.
Palmitoylation can occur enzymatically, through a conserved family of Asp-His-His-Cyscontaining protein acyltransferases (DHHC-PATs)20, or by autocatalytic mechanisms intrinsic to
a protein. Palmitoylation is unique in its reversibility with two thioesterases known to depalmitoylate. Dissecting the regulatory mechanisms of palmitoylation presents a significant challenge as the 23 DHHC-PATs of humans or mouse exhibit overlapping substrate specificities and
have no known consensus sequence21. Predictive algorithms based on known sites do exist, but
with unknown sensitivity and specificity outside of their training set22.

Isoprenoid modification, in particular farnesylation and geranylgeranylation, is an irreversible
post translational event which occurs at cysteines in the C-terminal region. One farnesyltransferase (FTase) and two geranylgeranyltransferases (GGTase-I and GGTase-II) can transfer one or
more isoprenoid moieties to C-terminal cysteines yielding thioether bonds23-25. FTase and
GGTase-I recognize the consensus sequence CaaX in which a is aliphatic the residue X determines modification by FTase (A, C, M, Q or S) or GGTase-I (L or F). GGTase-II has no known
5

consensus sequence23-25. Like other lipidation events, isoprenylation causes membrane targeting
and mediates protein-protein interactions23-25.

Protein cholesterylation is currently
only known in the hedgehog family
of secreted signaling molecules. Its
function is known on Sonic hedgehog (Shh), where it restricts the spatial diffusion to generate the morphogen gradients controlling vertebrate development26,27. Cholesterol
is installed by an autocatalytic processing event of the 45 kDa Shh
precursor in which an internal G-C
bond in an absolutely conserved
GCF tripeptide first undergoes an
autocatalytic N to S shift within the
so called Hedgehog/intein (Hint) Figure 3 Mechanism of cholesterylation in Shh.
domain28, a motif so named due to sequence, mechanistic and three-dimensional structure similarities between inteins and hedgehog protein autoprocessing domain (see Figure 3). The thiol
side-chain of cysteine of the GCF tripeptide nucleophilically attacks the carbonyl carbon of G,
forming an activated thioester intermediate. Subsequently, the intermediate undergoes a nucleophilic attack by cholesterol and the covalently cholesterylated 19 kDa N-terminal portion of Hh
6

is released. All biological activity is associated with this N-terminal fragment. Cholesterylation
null mutants show gross mispatterning and embryonic lethality in Drosophila embryos and mutations in humans result in holoprosencephaly27.

Glycosylphosphatidylinositylation has the most complex structure of lipid PTMs consisting of a
phosphoethanolamine linker to the protein, a glycan core, and a phospholipid tail29. GPI-anchor
modification results in localization to the outer leaflet of the plasma membrane and occurs within
a wide variety of biological processes29. The exact structure is heterogeneous and species dependent but like cholesterylation, GPI anchors are installed during a proteolytic event. A GPItransamidase complex recognizes a C-terminal GPI anchor attachment signal with no known
consensus sequence and cleaves the signal at the so named omega (ω) site30. A preassembled
GPI core structure is subsequently attached covalently to the nascent C-terminus30. Animals defective in glycosylphosphatidylinositol modification die as embryos29.

Lipid analysis
Despite their significance, lipids analysis on or off proteins has for decades remained difficult.
Progress in chromatography over the last five decades – in particular thin layer chromatography
(TLC) and gas-chromatography (GC) – opened the doors to lipid separation and identification1.
This trend has been built upon by advances in mass spectrometry, in particular matrix assisted laser desorption ionization (MALDI)31 and electrospray ionization (ESI)32. While powerful, these
advances are typically applicable only after lipid extraction and often hydrolysis. Deciphering
biological function requires identifying what lipids are where within cells, when, and their interactors. A host of techniques have thus been developed for lipid analysis. Strategies for indirect
7

detection include hydrophobic and fluorogenic membrane dyes (e.g. DiI33, filipin or 1,6diphenyl-1,3,5-hexatriene, DPH); lipid-binding proteins either internally expressed or externally
applied (lipid binding domains fused to fluorescent proteins34 or chemically conjugated proteins;
a few antibodies also exist); linked enzymatic assays (e.g. cholesterol oxidase) and chemical
tools to manipulate lipid levels such as cyclodextrins. Caution must be used with indirect techniques as they have varying degrees of sensitivity to external factors such as membrane composition or lipid accessibility. In addition, indirect techniques may suffer issues of selectivity, commonly interacting with more than one lipid. Alternatively, lipids may be directly detected directly with three different varieties of analogs (Figure 4).

Analysis with radioactivity
The oldest technique for lipid analysis involves radioactive molecules and autoradiography. Fatty
acids35, cholesterol36 or isoprenoids, or lipid precursors37, in particular acetate, pyruvate and
mevalonate, can be incorporated both in vivo or in vitro. This approach can reveal lipid localization in tissue slices38, image lipidated proteins within SDS-PAGE gels39 or be used to track lipidated proteins through chromatographic separations. For ultra-high resolution imaging, autoradiographic visualization can also be combined with electron microscopy (EM)40. Due to their identical chemical nature, radiolabeled reporters most faithfully recapitulate true biological behavior.
However, the approach cannot be easily combined with other common analyses such as immunohistochemistry (IHC). It also suffers from long exposure times (often weeks to months,
precluding live autoradiography) and the disadvantages of radioactivity. Detection times can be
substantially reduced with the use of 125I iodinated lipids41, but at the cost of changes in structure,
additional health exposure and regulatory overhead.
8

Analysis with analogs
The second and third variations of direct imaging involve chemically modified lipid analogs.
Fluorophore-conjugated lipids42-45 allow immediate imaging of lipids from proteins to organisms. Many fluors have been employed including BODIPY46,47, NBD48-50, dansyl51-53, rhodamine54, anthracene55,56, pyrene57-61, DPH62, naphthyl63 as well as others. Likewise, lipid analogss
bearing photochemical crosslinking groups64 can be employed to assay lipid interactions. To enable detection, crosslinking analogs typically contain an additional mark such as radioactivity, an
affinity handle or fluorophore. While useful tools, both analog variations are intrinsically limited
by the alteration of relatively small lipids44. Added fluorophores are often larger than the molecules to which they are fused and can greatly alter essential properties such as hydrophobicity
and charge. These changes can result in altered biological behavior44,65 such as lipid sorting by
differential partitioning66,67 or endogenous lipid recognition. For example, NBD-cholesterol has
been shown to orient itself “up-side-down” with the 3β-hydroxyl pointing into the membrane68
and with other BODIPY-69 and NBD-labeled50 lipids, fluors exist “looped back,” preferring the
surface rather than the membrane interior, apparently in reflection of additional polarity. Such interference has led to fluorescently labeled lipids being termed “ill-suited” to the study of lipid
microdomains67.

9

Figure 4 Classes of marked or modified lipids. Fluorescent (A)
or tagging (B) modifications can cause large perturbations in biological or chemical behavior. Radiolabeling (C) suffers from
long exposure times, but are the most faithful analogs.

Analysis with intrinsically fluorescent analogs
Intrinsically fluorescent lipids such as the dehydroergosterol (DHE)70-73 or polyenes like the naturally occurring cis-parinaric acid74, pentaene-carboxlic acids75,76 or didehydrogeranylgerany77
provide more faithful fluorescent reporters. However, DHE and parinaric acid suffer from low
quantum yield, rapid bleaching and ultra-violet (UV) excitation and emission, thus necessitating
specialized, UV-transparent imaging equipment78. Conjugated pentaene analogs are sufficiently
red-shifted to allow imaging with standard optics, but still suffer from rapid photobleaching and
require two-photon excitation to minimize fluorophore damage75. These non-ideal photochemical
10

properties often compel cellular loading with reporter concentrations sufficiently high that atypical pathways may be preferred79. In addition, while autoflorescent analogs maintain more structural similarity than analogs fused to fluorophores, even subtle alterations such as the presence or
absence of a methyl group80,81 or cis versus trans stereochemistry82,83 can significantly alter biological function. Indeed, the additional rigidity imposed by conjugated desaturation has been observed to modify both membrane structure and biological behavior: DHE disturbs membrane lipid packing density at concentrations of >1 mol%68 and is esterified >7-fold more rapidly than
[3H]cholesterol84; parinaric acid remains essentially unesterified in fibroblasts83 and can be cytotoxic85; and didehydrogeranylgeranyl is incorporated 60% as effectively as geranylgeranyl77.
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BIOORTHOGONAL CHEMICAL TECHNIQUES
The disadvantages of indirect labeling (dependence on multiple factors and accessibility) and direct labeling (alteration of properties) can be circumvented by directly marking the molecule of
interest with a small, specifically reactable chemical handle which causes minimal alteration in
cellular behavior. In this bioorthogonal strategy, the third strategy using analogs, reporter molecules are first metabolically incorporated, allowing proper metabolism and localization. Subsequently, the chemical handle is interrogated to covalently add tags for visualization or affinity retrieval. These are typically fluorophores, some of which are fluorogenic, or common affinity tags
such as biotin, which can be probed with Western blots or used in affinity retrieval. Especially
for lipids, it must be noted that the advantage of similar biochemical behavior is likely abrogated
after addition of visualization tags. The application of bioorthogonal chemistry to live lipid analysis86 thus necessitates great attention to behavior before and after analog modification. Table 1
contrasts bioorthogonal approaches with intrinsically labeled molecules.

Bioorthogonal techniques require unique constraints within chemical reaction space and have only recently been introduced. The reaction must occur in cellular environments (i.e. at physiological temperature and pH within aqueous solutions containing salts, nucleophiles and oxygen); it
must be highly specific, not reacting with the functional groups present in cells; it must proceed
efficiently at very low concentrations; the reaction must occur in a biologically relevant time
frame (seconds to hours); it must be irreversible; and the chemical handle must be biologically
inert (bioorthogonal): it must not be metabolized by the cell, not present within the cell, nor alter
cellular recognition or metabolism. These very specific bioorthogonal needs have been best met
12

by two general chemistries: the Staudinger reaction and Huisgen azide-alkyne cycloadditions
(Figure 5).

Table 1 Contrasting properties of bioorthogonal probes and tagged analogs.

Tagged molecules

Attribute
Size

Usually much larger (excepted by
intrinsically fluorescent analogs)
Similar to very different
Same to reversed charge

Small change

Hydrophobicity
Charge

Very little difference
No change
Generally similar to native moleOverall
chemical
cules (but substantially altered after Generally different
similarity
click reaction)
Limited; usually stepwise or cell exLive imaging
Usually possible (tag dependent)
terior
Tolerated as part of an organic molBiocompatibility
Tag dependent
ecule
Usually absent (although autofluoOrthogonality
Absent (N3) and infrequent (–≡)
rescence or pigments can interfere)
Reaction specificity Specific with low background
No reaction after incorporation
Modularity
Highly modular
Limited
Synthetic accessiRelatively accessible
Tag dependent
bility
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Figure 5 Bioorthogonal chemistries in various applications.

The Staudinger reaction
Bioorthogonal chemistry was pioneered by the Staudinger reaction in 2000 by Bertozzi and
coworkers, who employed the selective reaction between a modified phosphine and an azide in
biological conditions87. Through rearrangement of an aza-ylide intermediate, a stable amide bond
results between the oxidized phosphine reagent and the azide bearing analog (Figure 5). Due to
the phenylated phosphine size and hydrophobicity, analogs employed for bioorthogonal chemistry using the Staudinger reaction carry an azide. In the original application, metabolic incorporation of N-azidoacetylmannosamine (ManNAz) in HeLa and Jurkat cells labeled surface glycans,
which were then reacted with a biotin derivatized phosphine and visualized with fluorescent avidin. The reaction has been further expanded by the development of a “traceless” version, in
14

which amide bonds are formed with exit of the phosphine88. Multiple phosphine reagents have
been developed including fluorogenic dyes which remain quenched until reacting including a
coumarin derivative89 and a fluorescein compound90 initially silenced by a fluorescence resonance energy transfer (FRET). The phosphines have a distinctive smell but are not particularly
toxic and have been applied to live cells90,91 and in mice92. Within lipids, the Staudinger reaction
has since been applied to fatty acids93-99, isoprenylation100-105, targets damaged by lipid peroxidation106, gangliosides107 and ceramide synthesis108. Despite the large body of work, the reaction
suffers from relatively slow reaction kinetics and sensitivity of the phosphine to air oxidation109.
Unfortunately, success in improving phosphine reactivity also increased rates of oxidation109 and
other bioorthogonal chemistries have been consequently sought.

Click chemistry and CuI-catalyzed [3+ 2] azide-alkyne cycloadditions (CuAAC)
Shortly after the biological application of the Staudinger reaction, in 2002 Meldal and coworkers110 as well as Sharpless and coworkers111 discovered that copper(I) can catalyze Huisgen azide-alkyne cycloadditions to give 1,4-disubstituted 1,2,3-triazoles (Figure 5). The reaction proceeds in aqueous conditions at room temperature rapidly with high yield and was illustrated on
proteins, nucleic acids and sugars. The field of CuI-catalyzed [3+ 2] azide-alkyne cycloadditions
(CuAAC) has since exploded112-114 with applications of terminal alkyne and azide analogs applied to all classes of biological building block. While it is only one of a family of reactions exhibiting the modular philosophy and properties of “click chemistries,”115 the ease and widespread
applicability of Huisgen azide-alkyne cycloaddition have lead it to it commonly being known by
the “click chemistry” moniker. The cycloaddition was advanced by the development of copper
ligands that increase reaction kinetics catalyst stability116,117 and CuAAC has been applied to fat15

ty acids94,96-98,118-123, isoprenoids, cholesterol124, choline125, phospholipids86 and azido diacylglycerol (DAG)126. Despite its utility, the metal-catalyzed cycloaddition remained limited by the
requirement of cytotoxic copper which prevented live imaging that remained possible using the
Staudinger reaction.

Strain promoted alkyne-azide cycloadditions (SPAAC)
Consequently, in 2004 Bertozzi and coworkers developed a copper-free version of azide-alkyne
cycloaddition catalyzed by the strain of a cyclooctyne127 (Figure 5), the smallest stable cycloalkyne, and illustrated its use again on glycans128. Strain-promoted alkyne-azide cycloaddition
(SPAAC) generates the same triazole ring and has been further developed with more stable and
more reactive cyclooctyne derivatives129-131. The lack of copper lends it particularly well to in vivo imaging and the strategy has been applied to live visualization of a phosphatidic acid analog132 and to surface proteins bearing azido caprylic acid (Az-8)133.

Considerations in choice of bioorthogonal chemistries and reaction pairs
Owing to its fast kinetics, CuAAC has been found to be more rapid and sensitive in the detection
of bioorthogonal probes129 and in particular with lipid analogs94,97. Both the Staudinger reaction
and SPAAC can both be used in live imaging to circumvent copper toxicity, although the stability of reagents in click chemistry reactions increases its appeal. In click chemistry, reacting alkyne analogs with azido probes produced a lower background than the respective reaction with
azido analogs and alkyne probes94,134,135 but the side products remain unknown. Many SPAAC
reagents are exceedingly hydrophobic and we have found them poorly suited to work on cell interiors or permeabilized cells: they tend to function as dyes rather than reagents which can be
16

washed away. Fluorogenic reagents, in particular coumarin derivatives, are appealing possible alternatives to reduce such background86,89,118.
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The biology and chemical properties of bioorthogonal handles
Both click chemistry and the Staudinger reaction employ azides and many analogs modified either with an azide or alkynes have been synthesized and employed (Table 1 and sections below).
As for all modified molecules, consideration must be given to their possible biological presence,
their potential biological activity and the possibility for change in alterations in chemical behavior.

The azide in biology
The azido group is unique within organic chemistry for its ease of introduction and reactivity.
Azides are typically added with well-established nucleophilic substitution or azo transfer reactions and can be substituted for a methyl. As an anion, the azide displays toxicity similar to cyanide and, perhaps consequently, is virtually non-existent within biology136: exactly one azido
containing product from a dinoflagellate137 is listed in the Natural Products Dictionary and 2amino-3-azidopropanoic acid can be produced by Salmonella in the presence of azides138. In contrast, synthetic organic azides have for decades functioned as photolabile probes64 and appear to
be biologically well tolerated: 12-Az-12 causes no cellular toxicity in CEM cells139 and multiple
azido-derivatized fatty acids support the growth of E. coli140,141, pseudomonad142 and S. cerevisiae143 fatty acid auxotrophs. In our own work, we have not observed toxicity of azido fatty acids up to 100 µM in Jurkat, HeLa, RAW and DC2.4 cells. However, caution must always be used
as toxicity of azido derivatized sugars has been observed144, 12-Az-12 was found to be an inhibitor of HIV replication139 and it inhibits mitochondrial phosphate uptake at 100 µM145. Likewise,
organic azides are part of four bioactive, FDA approved drugs (3′-azidothymidine, an anti-HIV;
Azidocillin and Azidamfenicol, antibiotics; and zidometacin, an anti-inflammatory). Metabolism
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of aryl azides has been observed in yeast143 and the reduction of aryl azides to amines was seen
after ex vivo exposure to mouse liver microsomes146.

The alkyne in biology
Contrasting the biological absence of azides, alkynes are found in a large diversity of natural
products from fungi, moss and lichens, plants, marine algae, tunicates, sponges, insects, frogs
and in traces quantities, even in mammals147. Plants, mosses and fungi in particular can accumulate high concentrations of alkynyl lipids, and, of the >2000 polyacetylenes known, more than
1100 are found in the plant family Asteraceae (the aster or sunflower family)147. Acetylenic
groups are found both internally and at molecule terminals148,149. Both natural and synthetic alkyne lipids have been shown to have anticancer148, antibacterial, antifungal, anti-HIV and pesticidal activities150. Several alkyne-containing compounds, including ethynylic steroids, are approved drugs and various acetylenic compounds are known to inhibit monoamine oxidases A and
B, aromatase, cytochrome P450 isozyme families including 1A, 3A and 22A, and thymidylate
synthetase151. Others serve as cholinergic and muscarinic agents151. Terminal alkyne compounds,
in particular 17-octadecynoic acid (ODYA) or alk-16, are known irreversible mechanism-based
inhibitors of plant152 and mammalian153-155 fatty acid ω-hydroxylases, as well as P450 hydroxylases156,157. Alk-16 is unable to support growth of unsaturated fatty acid auxotrophs of E. coli or
S. cerevisiae although the fatty acid was found in membranes and could be esterified158. The
equivalent experiment with saturated fatty acid auxotrophs was not performed, however the
myristic acid analog alk-12 is a better substrate for S. cerevisiae N-myristoyl transferase than
myristic acid159. In our hands, with Jurkat, HeLa, RAW and DC2.4 cells, alkyne fatty acids up to
100 µM show the same overt lack of toxicity as azido fatty acids but we did not examine possi19

bly inhibited enzymes. Synthetic acetylenic analogs can be made through synthesis of an analog
desaturated at a terminal secondary-primary carbon pair, or by the addition of an ethynyl to an
accessible atom. Alkyne synthetic schemes can be more complicated than their equivalent azides
due to the requisite alteration in carbon-carbon bonds, although not necessarily, as an ethynyl
might also be added to a heteroatom.

Chemical properties of azides and alkynes
Like the cyano (–C≡N), the atoms of acetylene (–C≡CH) and azido (–N=N+=N-) groups exist
within a π electron rich cylinder. An acetylene group attached to a carbon forms a linear array of
four atoms which emanate at the angle of the originating carbon hybridization; azides in contrast
are bent slightly off axis with a C-N1 angle of around 120°. Due to the linear alignment, the distance from a terminally ethynylated carbon to the final hydrogen of the acetylene (3.72 Å) is actually longer than the corresponding maximum distance of an ethylated carbon to one of its terminal hydrogens (3.06 Å) despite the shorter carbon-carbon bond (1.21 Å vs. 1.54 Å). For lipids,
this linear “kink” and its position can have significant implications for enzyme recognition159 and
membrane function: only three of 16 isomers, 7-, 8- and 10-octadecynoic fatty acids, can support
growth of an S. cerevisiae unsaturated fatty acid auxotroph158. Unlike ethynyl groups, azides are
mostly – but not perfectly – linear, and must be terminal, while alkynes can exist within a hydrocarbon chain. In length, azides are shorter than an ethynyl group yet still slightly longer than an
ethyl group (3.29 Å from the azido bearing carbon to the last nitrogen). Both functions are relatively nonpolar: the dipole moment for phenylazide (C6H5-N3) is 1.44 D and for phenylacetylene
(C6H5–C≡CH) 0.66 D160; these values contrasts to benzonitrile (C6H5–C≡N) at 4.05 D. Both
groups have a similar effect on water solubility: at 25 C, phenylazide is soluble to 4.2 mM161 and
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phenylacetylene to 4.46 mM162 (these values contrast with benzene at 22.1 mM163). The molecular volume of both functional groups is small: the conformational preference (–∆G°) for the
equatorial position of cyclohexane is 1.70 kcal/mol for a methyl (–CH3); 1.75 kcal/mole for an
ethyl (–CH2–CH3); 0.48 ± 0.07 kcal/mol for an azido164; and 0.41 ± 0.05 kcal/mol for an acetylene group165.

Thus, azides and acetylenes are around the length of an ethyl group (and are both linearly longer)
but occupy less volume and are rigid. They are more polar, but not drastically so, and more reactive, though stable under typical physiological temperatures and solvent conditions (aqueous solutions around neutral pH containing many dissolved salts and other substances). Neither adds
charge and they are usually biologically stable. However, both stability and unexpected biological effects should be studied; the careful controls required to exclude side-effects remains unexamined for many published analogs. Alkynes and azides thus offer a good opportunity to faithfully recapitulate cellular localization, metabolism and enzyme recognition, while offering chemical reactivity.
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Bioorthogonal lipid probes
A wide variety of alkyne and azide probes have been described for many lipid classes. In particular, owing to their synthetic accessibility and utility in photocrosslinking, a wide variety of azido
(especially aryl-azide) lipid analogs have been published. For decades, they have been employed
to identify lipid-binding proteins or membrane domains. Reported azide and alkyne lipid analogs
include saturated and unsaturated fatty acids, isoprenoids, glycosides, 4-hydroxynonenal (HNE, a
byproduct of unsaturated lipid peroxidation) sterols and sterol derivatives, sphingosines,
ceramides and diacylglycerol. However, only a few have been subsequently utilized in
bioorthogonal chemical investigations. In those cases, frequently a corresponding alkyne has
been synthesized due to background labeling issues. The pair also serves as an internal control,
similar to N- and C-terminal tagging with fluorescent proteins.

Probes for fatty acids
Azido and alkyne fatty acid probes from 10 to 18 carbons in length have been described and employed using both the Satudinger reaction and CuAAC with fluorescent and Western blot detection (see Table 2). The relative activity of az-12 and alk-12 was previously studied in depth for S.
cerevisiae NMT (~140% and ~100%-120% relative to myristic acid, respectively139,159) and subsequent studies have employed well studied, known fatty-acylated proteins such as
Lck93,94,119,120, various forms or fusions of Ras94,118,119, LAT94,119 GAPDH118,119 to validate proper
incorporation. Direct comparison of alkyne and azido analogs of myristic acid (alk-12 and az-12)
as well as stearic acid (az-15 and alk-16), revealed very similar incorporation profiles indicating
that the orientation has little influence on cellular recognition of fatty acids94. In contrast, work to
isolate palmitoylated mitochondrial proteins revealed a large discrepancy between iodopalmitoyl
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CoA and az-1495, indicating that the large halogen alters cellular processing. As described below,
these probes have been applied to visualizing fatty acids in membranes and on proteins, as well
in discovering the identity of fatty-acylated proteins.

Probes for isoprenoids
Geranyl103,105,166, farnesyl101,105,167 and geranylgeranyl102,168 analogs have been described in both
azido and alkyne varieties (see Table 3). FTase and GGTases can show both substrate tolerance100 and specificity, allowing some degree of control over the prenyl analog incorporation104.
In contrast to fatty acid probes, several analogs incorporate hetero atom changes in their backbone; despite the change in hydrophobicity, this alteration seems to be well tolerated such as for
alk-FFP and Alk-GPP1166,167, though not always, as in the case of GPP2, which was ineffective
at displacing the natural substrate100.

Probes for other lipids
A propargyl analog of choline125 and analogs of phosphatidic acid132 have also been described
(See Table 4). Metabolic labeling with propargylcholine resulted in biosynthetic incorporation
into phospholipids which were incorporated into expected classes of lipids in CHO cells with
similar efficiency to choline125. The three phosphatidic acid analogs include a cyclooctyne derivative which allowed live visualization of membranes in cell culture using a fluorogenic coumarin
azide132 but no comparison of analog with native phosphatidic acid. The phosphate of all analogs
was capped with a S-acetylthioethyl group (SATE) which is rapidly cleaved in living cells by esterase to release the free phosphate132.
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Table 2 Bioorthogonal probes of fatty acids and their applications
Rxn. Incorp.

Probe

Application

Ref.

Visualization of protein short chain acylation in PC3 cells

121

Surface labeling of proteins engineered to be labeled with
microbial lipoic acid ligase (LplA)

133

OH

Alk-8

x

OH

Az-8

SPAAC

OH

Alk-9

x

X

x

Visualization of protein short chain acylation in PC3 cells

121

OH

Alk-11

x

x

x

Visualization of protein short chain acylation in PC3 cells

121

OH

Az-11
Az-11-CoA

x

x

x

x

x

NMT-mediated tagging of overexpressed proteins in E. coli

97,98

x

x

x

x

97,98

x

x

x

x
x

NMT-mediated tagging recombinant peptide
Visualization of protein myristoylation in multiple cell lines
and myristic acid in HeLa cell membranes
Visualization of protein myristoylation in PC3 cells
NMT-mediated tagging of overexpressed proteins in E. coli
Visualization of protein myristoylation in Jurkat cells with
and without apoptosis and COS-7 cells overexpressing EGFP
fusions
Large scale ID of myristoylated proteins and their validation
in fully solubilized Jurkat cells
Determination of palmitoylation turnover in Jurkat cells
NMT-mediated tagging recombinant peptide

O

N3

Detection

Staudinger
CuAAC
In vivo
Ex vivo
In vitro
Population
IP
On blot (Western)
In gel fluorescence
Histochemical
Mass spectrometric

Structure

Prot.

O

x

x

O

O

N3
O
N3

S CoA
O

OH
O

S CoA
O

Alk-12

Alk-12-CoA

x

x

x

x

x
x

x
x

x

x

x

x

x

x

x

x

x

x

x

x
x

x

x

x

x

x
x

x
x

x
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x

94
121
97
118

119
120
97

x
x
OH

N3
O

OH
O

S CoA
O

OH

N3
O

S CoA

N3
O

Az-12

x
x

x
x

x
x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

Alk-14

Alk-14-CoA
Az-14

x

Az-14-CoA

x

N3

OH
O

Az-15

x

x

x

x

x

x
x

x
x

x

x

x

x

x

x
x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
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x
x

Visualization of protein myristoylation in RAW264.7 cells
Visualization of protein myristoylation in multiple cell lines
Visualization of myristoylation on proteins predicted to be
post-translationally modified during apoptosis
Large scale ID of myristoylated proteins and their validation
in fully solubilized Jurkat cells
Visualization of protein myristoylation/palmitoylation in
multiple cell lines
Visualization of protein myristoylation/palmitoylation in PC3
cells
Large scale ID of myristoylated/palmitoylated proteins in fully solubilized Jurkat cells their validation
Visualization of protein myristoylation/palmitoylation in
Jurkat cells, COS-7 cells overexpressing EGFP-Ras fusions
and RAS IPed from mice
Visualization and identification of bacterial lipoproteins from
E. coli
NMT-mediated tagging of peptide
Visualization of protein palmitoylation on autocatalytic
HMGCS and GAPDH
Visualization of protein myristoylation/palmitoylation in
RAW264.7 cells
Identification of mitochondria protein palmitoylation through
chromatographic separation followed by protein ID
Visualization of protein palmitoylation in RAW264.7 cells
Visualization of protein palmitoylation in multiple cell lines
and stearic acid in HeLa cell membranes
Large scale ID of palmitoylated proteins and their validation
in fully solubilized Jurkat cells identifying

93
94
96
119
94
121
119

118

169
97
118
93
95
93
94
119

OH
O

OH

N3
O

Alk-16

Az-16

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
x

x
x
x

x
x
x

x
x

x

x

x

x

x
x

x

x

x

x

x
x

x

x

26

Visualization of protein palmitoylation in multiple cell lines
and stearic acid in HeLa cell membranes
Visualization of protein palmitoylation in PC3 cells
Large scale ID of palmitoylated proteins from Jurkat cell
membranes and their validation by overexpression
Large scale ID of palmitoylated proteins and their validation
in fully solubilized Jurkat cells
Large scale ID from DC2.4 dendritic cells
Determination of palmitoylation turnover in Jurkat cells
Visualization of protein palmitoylation in RAW264.7 cells

94
121
122
119
123
120
93

Probe
Az-FPP1

Staudinger
CuAAC
In vivo
In vitro
Population
Purified prot. or IP
Peptide
On blot (Western)
Fluorescence
Mass spectrometric

Table 3 Probes for isoprenyl lipids.

x
x

Az-F-OH

x

Az-GPP

x
x
x

Az-GPP1 (APO-GPP)
Az-GPP2 (AAA-GPP)

Az-GG-OH
Az-GGPP
Alk-GPP
Alk-FPP1
Az-FPP2

x

x

x

x

x
x

x

x
x
x
x

x

x
x

x
x x
x x

x
x

x

x

x

x x
x
x
x
x x

x

x
x

x
x
x
x

x
x

Application

Visualization of farnesylation in COS-1 cells and identification of 18 modified
proteins
N-terminal geranylation of peptide by FTase
Visualization of farnesylation in COS-1 cells and identification of 18 modified
proteins
N-terminal geranylation of peptide by FTase
Geranylation of peptides and proteins by FTase.
Geranylation of peptides and proteins by FTase.
Identification of geranylgeranylated proteins through 2D gel separation and identification
Visualization of geranylgeranylated proteins
Visualization of geranylgeranylated proteins in HEK293A and mouse tissue cells
Geranylation of eGFP for FRET between added fluorophore
C-terminal farnesylation for subsequent covalent attachment
C-terminal farnesylation for subsequent covalent attachment
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Ref.
101
105
101
103,105
100
100
102
168
104
166
167
167

Table 4 Probes for other lipids.
Probe
Alk-Cho
Alk-PA1
Alk-PA2
Calk-PA

In vivo
X

CuAAC
X

X
X
X

X
X

SPAAC

Application

Imaging choline phospholipids in
CHO cells and mice.
Imaging lipid distribution in cells.

X
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Ref.
125
132
132
132

Applications of lipid bioorthogonal chemical reporters

Visualization of lipids in membranes
The application of bioorthogonal chemistry to the study of lipids in cells and their membranes is
one of the most promising advances in lipid imaging. The Staudinger reaction and click chemistry allow work with stable, nonradioactive lipid analogs with high sensitivity which do not suffer
the disadvantages of bulky fluorophores and which are relatively unperturbed. Likewise, the
need for specialized UV transparent microscopes is negated and analysis is made both accessible
and rapid. This approach has been applied to myristic and stearic acids, imaged with rhodamine
addition by CuAAC in HeLa cells revealing strong, detergent (0.1% triton X-100) and methanol
sensitive membrane labeling94.

Propargyl choline was imaged in CHO cells and in mice125. In both cases, membrane structures
such as the plasma membrane were clearly labeled125. The use of regents of different cell permeability (fluorescently tagged streptavidin and Alexa Fluor 568) also allowed distinction between
surface and internal analog125. As for fatty acids, choline analog did not colocalize with any one
subcellular markers in CHO cells125, likely a reflection of the complex composition of cellular
membranes and their fast diffusibility. Supporting techniques used to analyze lipid rafts, different
detergents had marked effects on labeled lipid: tween-20 does not alter the signal of fatty acid
analogs94, but triton X-100 is sufficient to remove membrane signal completely for fatty acids or
choline containing lipids94,125.
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Phosphatidic acid imaging by the three different reporters yielded similar images in RAW cells
whether by CuAAC after fixing or by live imaging SPAAC with the cyclooctyne. The reporters
remains membrane bound after reaction in live cells, however no further study was done to determine the effect of reaction132 and the subcellular localization of any analog has not yet been
examined.

Visualization of lipid PTMs on isolated proteins
Bioorthogonal chemistry provides a convenient and nonradioactive alterative to determine if a
particular protein of interest is lipidated both in vivo and in vitro. Purified proteins can be modified in reconstituted enzymatic reactions or proteins can be immunoprecipitated (IPed) following
metabolic incorporation and reacted while held on the solid phase. Such analyses have been performed for multiple fatty acylated proteins including Ras, LAT, Fyn, PAK2, Lck and others from
cells93,94,96,118-120,123 or animals118, as well as for prenylation: isolated proteins have been examined for farnesylation (Ras and Hdj-2101), geranylation100,166 and geranylgeranylation (progerin in
the study on Hutchinson-Gilford progeria syndrome168). Immunoprecipitation and in-gel fluorescence combined with mutational analysis is helpful to establish the exact residues of modification. In the case of IFITM3, a HA-tagged overexpression was studied to establish the role of
palmitoylation in membrane clustering necessary for activity123. As an alternative to antibodies, a
His tag can also be employed, as was done to verify a tagged, overexpressed bacterial lipoprotein169. Visualization has been achieved by the Staudinger reaction93,94,96-98,100,101 or CuAAC94,97,98,118-120,123,166,168,169. SPAAC has also been employed to visualize a specific engineered
protein in the unisolated environment of a cell surface133. Validation of protein lipidation status
may alternatively be achieved by transient overexpression, reaction and examination of signal, as
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was done by in-gel fluorescence for the validation of many candidate palmitoylated proteins
identified by mass spectrometry122 or on blot in the overexpression of EGFP-Ras fusions in
COS-7 cells118. Finally, an expected site of lipidation can be fused to proteins such as GFP for
subsequent IP, reaction and detection, or for live fluorescence microscopy. This technique was
taken to validate 15 proteins predicted to undergo post translational myristoylation during apoptosis96 and benefits from the use of general IP reagents as well as the ability to examine in vivo
membrane localization. Visualization of fatty-acylation on isolated proteins has allowed radioactivity-free study of the turnover of palmitoylation120.

Visualization of lipid PTMs in proteomes
Visualization of lipid PTMs during cell state and comparison of preferences have been globally
surveyed. Fatty-acylation machinery preference for various fatty acid chain lengths from myristic
to stearic acids has been surveyed on blot with the Staudinger reaction in RAW93 and Jurkat
cells94. The profile of palmitoylated mitochondrial proteins has also been profiled on blot after ex
vivo az-14-CoA incorporation95. Alkyne analogs from myristic to stearic acids (alk-12, alk-1 and
alk-16) were directly compared to their azido counterparts (az-12 and az-15) using CuAAC with
in-gel fluorescence94. Many cell lines were profiled, each showing uniqueness as well as commonalities suggesting both common pathways and distinctive regulation of fatty-acylation94.
Both on-blot and in-gel, it was shown that the signal of NMT labeled proteins, which are preferentially labeled with shorter length fatty acid chains, remains after treatment with hydroxylamine, which cleaves the thioester bonds of proteins palmitoylated with longer fatty acids93,94,121.
A later study extended the range of short chain fatty acids downward to include alk-8, alk-9, and
alk-11121. In PC3 cells and it was discovered that signal from shorter chain lengths are hydroxyl31

amine sensitivity121, consistent with proteins such as acyl carrier proteins that are covalently attached to shorter length fatty acids attached via thioester bonds170. Bacterial chain length preference was also surveyed, showing that the palmitic acid analog alk-14 was best incorporated onto
proteins in E. coli169. Using the Staudinger reaction, post-translational myristoylation in Jurkat
cells has been examined during apoptosis96,118, leading to validation of proteins with newly exposed NMT sites96. Jurkat cell geranylgeranylation has been profiled with CuAAC, one and twodimensional electrophoresis and in-gel fluorescence102 as well as in mouse embryo fibroblasts168,
and farnesylation was visualized by the Staudinger reaction and blotting in COS-1 cells101.

To image the localization of fatty acylated proteins in cells, two studies have employed CuAAC
in histochemical examination in HeLa cells94, PC3, RAW264.7 and mouse fibroblast L-cells121
using clickable analogs from myristic to stearic acid. Methanol or triton X-100 have been employed to remove membrane lipids, leaving behind fixed proteins which were then visualized.
While no particular colocalization with any subcellular marker was observed94,121, both studies
found that fatty-acylated proteins are distributed in vesicle and membrane like structures, consistent with membrane targeting of this class of PTM. Interestingly, in PC3 cells, the cleavage
furrow formed during cytokinesis is rich in palmitoylated proteins121, indicating a function for
fatty-acylation in the segregation events of membranes and other cellular materials during cell
division. Also notably, during interphase, distinctive colocalization of tubulin and palmitoylation
was occasionally pronounced121, perhaps providing insight into the function and timing of tubulin palmitoylation171.
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Identification of lipid-modified proteins
The ability of bioorthogonal chemistry to attach an affinity handle after incorporation offers an
obvious advantage to more traditional biochemical isolations such as analog-biotin fusions.
Bioorthogonal techniques have been used to study fatty-acylation122, farnesylation101 and modification by 4-hydroxynonenal (HNE)106,172 (a reactive unsaturated α,β aldehyde generated during
reactive oxygen species (ROS) damage by peroxidation of polyunsaturated fatty acids (PUFA)
which attacks cellular nucleophiles). In such analyses, metabolically lipidated proteins are labeled with a biotin secondary reagent and captured on streptavidin. Due to the very high affinity
of the streptavidin biotin interaction, proteins can be identified by on-bead digestion with trypsin101,106,122 and subsequent mass spectrometric identification. An alternative has been developed
in the form of a photocleavable linker, but this requires the use of glass beads and induced noticeable UV degradation of UV-eluted proteins172.

In fatty acid analysis, alk-16 (ODYA-17) and CuAAC were applied to identify palmitoylated
proteins from Jurkat cell membranes by on-bead digestion and MudPIT proteomics173. 125 proteins were identified with high confidence including known GTPases, G-protein-subunits and receptors173. Of the many new candidate fatty-acylated proteins, a previously unknown family of
uncharacterized serine hydrolases termed FAM108 was discovered; for this family, palmitoylation determines plasma membrane localization173. Although alk-16, a stearic acid analog,
was used, many N-myristoylated proteins were also selectively retrieved173, consistent with metabolic processing and fatty-acylation heterogeneity. Azido-farnesyl fed to COS-1 cells and subsequent application of the Staudinger reaction resulted in the identification of 18 putatively farnesylated proteins101. Likewise, alkyne106,172 and azide106 HNE identified multiple proteins tar33

geted by HNE. These included proteins involved in stress response106 like heat shock proteins
(HSP), as well as plasma proteins such as human serum albumin (HAS) and apolipoproteins172.
Sites of modification were identified in the latter case showing modification to take place mostly
on histidine, followed by lysine and then cysteine172.

Lipid modified proteins can also be identified using bioorthogonal chemistry without the use of
affinity handles. In this case, detection tags such as fluorophores are installed and proteins are
separated using traditional chromatographic or electrophoretic102 techniques. The isolated proteins are then identified by mass spectrometry. This was applied to identify 10 geranylgeranylated proteins of the Rab and Ras families from MCF-7 cells102 and 21 putatively palmitoylated
proteins from mitochondria95.

Other applications
Bioorthogonal lipid analogs have found use in a variety of other contexts. To enable latter chemical modification, bioorthogonal chemistry can be combined with enzyme-mediated protein tagging to install a derivatizable lipid in vivo or in vitro. This has been achieved by geranylation100,
farnesylation167 and in E. coli simultaneously overexpressing Candida albicans NMT a recombinant protein with an N-terminal NMT recognition sequence97,98, offering a strategy suited to
large scale production. Likewise, surface proteins engineered to be substrates for azido caprylic
acid (Az-8) transferred by a microbial lipoic acid ligase can be easily visualized by SPAAC
fluorophores133. Derivatizable liposomes allow modular installation of multiple targeting reagents, such as antibodies or peptide ligands, and imaging agents. Liposomes with terminal acetylenic lipids have been applied to imaging the uptake by UMR-106 cells when derivatized with a
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FITC dye and an integrin receptor uptake peptide GRGD174. Likewise, azide phospholipids allowed derivatization with an N-terminally labeled fluorescent peptide, GPGGCGG, which was
taken up by HeLa cells175. Finally, lipid modification of DNA constructs accelerated the uptake
of oligonucleotides and did not inhibit biological activity176.

Scope of this work
Building on this foundation, this work set out with two goals. First at the level of proteins, to develop a robust platform for affinity enrichment and identification of chemical reporter modified
proteins. This system must have low background, must keep all proteins in solution, and must allow quantitative release of captured proteins. Second, this work sought to apply bioorthogonal
techniques to one of nature’s most conserved and important lipids: cholesterol.
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MATERIALS AND METHODS

Proteomic analysis

HPLC-MS analysis of biotinylated detection tags
Biotinylated detection tags were diluted to 100 µM in 50 mM triethanolamine (TEA), 150 mM
NaCl and treated for 1 hr with the different reductants listed in Figure 8. The reactions were terminated by reverse phase extraction on a C18 column, washed, eluted and vacuum concentrated.
Samples were analyzed on a Waters Acquity HPLC and separated on a C18 column. The gradient of solvent A (water with 0.1% TFA) and solvent B (CH3CN with 0.1% TFA) was increased
from 1% B to 40% B over 9 min, 60% B for 1 min and 100% B for 2 min. Mass to charge ratios
were determined on a Thermo Scientific TSQ Vantage triple stage quadrupole.

Cell culture and metabolic labeling
Jurkat T cells (human T lymphoma) were cultured in RPMI medium 1640 supplemented with
10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 mg/mL streptomycin (P/S). Cells
were maintained in a humidified 37 °C incubator with 5% CO2. Trypan blue exclusion was used
to determine cell viability. Cells were labeled at 5 x 106 cells/mL for 8 hours in 25 µM myristic
acid analogs (alk-12 and az-12) or 50 µM palmitic (alk-14) and stearic acid analogs (az-15 and
alk-16) in RPMI 1640 containing 2% charcoal dextran-treated FBS (CD-FBS) and P/S. Cells
were spun down, washed once with PBS, snap frozen in liquid N2 and stored at -80 °C.
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Preparation of total cell lysates
Cells were lysed first in a hypotonic buffer (5 mM TEA, pH 7.4, 5 mM MgCl2, 10 mM PMSF,
Roche Complete EDTA-free protease inhibitors) to which benzonase at 1000 U/mL had been
added. Cells were intermittently vortexed and sonicated for 30 min at 4 ºC after which an equal
volume of 8% SDS, 300 mM NaCl, 100 mM TEA pH 7.4 was added. Cells were again sonicated
and incubated for 10 min at RT room temperature (RT); at this point the solution was clear. The
supernatant was centrifuged at 10,000 g, 0 ºC for 30 min and the supernatant removed and stored
at -80 ºC until future use. Protein concentration of cell lysates was determined by a BCA assay
using BSA as a standard and equal amounts of protein from 2-20 mg were precipitated overnight
with 8 volumes of methanol at -80 ºC. The precipitated proteins were resolubilized to 5-15
mg/mL in 4% SDS, 150 mM NaCl and 50 mM TEA pH 7.4 containing 0.5 mM PMSF and 1x
Roche Complete protease inhibitors with sonication.

CuAAC labeling of cell lysates and in-gel fluorescence scanning
Cell lysates were labeled in 4% SDS, 150 mM NaCl and 50 mM TEA with protease inhibitors at
1 mg/mL. Protein was reacted for 2 hr at RT with 100 µM azido- or alkynyl-Rho or biotinylated
detection tags from a 10 mM DMSO stock solution, 1 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) from a 50 mM freshly prepared aqueous stock solution, 100 µM tris[(1-benzyl1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) from a 25 mM DMSO stock and 1 mM CuSO4 from
a 50 mM freshly prepared aqueous stock solution. The reactions were terminated by the addition
of 8 volumes of -20 °C methanol and placed at -20 °C overnight. Precipitated proteins were pelleted by centrifugation (18,000 g, 10 min, at 0 °C) and the supernatant discarded. Protein pellets
were air dried for 10 min, resuspended in 35 µL of resuspension buffer (4% SDS, 50 mM trieth37

anolamine pH 7.4, 150 mM NaCl), diluted with 12.5 µL 4X reducing SDS-loading buffer (40%
glycerol, 200 mM Tris-HCl pH 6.8, 8% SDS, 0.4% bromophenol blue) and 2.5 µL 2mercaptoethanol, heated for 5 min at 95 ºC and ~20 µg of protein was loaded per gel lane for
separation by SDS-PAGE (10% or 4-20% Bio-Rad Criterion Tris-HCl gel). Protein gels were
then visualized by in-gel fluorescence scanning with an Amersham Biosciences Typhoon 9400
variable mode imager (excitation 532 nm, 580 nm filter, 30 nm band-pass).

Immunoprecipitations and CuAAC labeling/in-gel fluorescence scanning
Jurkat cells were labeled and lysed as described above with the exception that 8% SDS was replaced with 2% Brij-97 for a final lysate in 1% Brij-97, 50 mM TEA pH 7.4 and 150 mM NaCl.
500 µg of Brij cell lysate was mixed with 10 µL protein G beads and 2 µg anti-HSP90 and incubated for 1 hr with agitation at RT. Beads were washed 3x with Brij-97 buffer and resuspended
in 14 µL of 4% SDS buffer containing all CuAAC reagents. Histone IPs were performed as described before177. Beads were reacted for 1 hr at RT after which 5 µL of 4X LDS sample buffer,
1 µL BME was added and 20 µL of supernatant taken and analyzed by SDS-PAGE. Gels were
scanned as described above.

Transfection and metabolic labeling of constructs bearing exogenous tags
293T cells were grown to 95% confluency in DMEM supplemented with 10% and 100 U/mL
penicillin and 100 mg/mL streptomycin. Cells were transfected with various plasmids using
lipofectamine-2000 according to the manufacturer’s instructions. After 10 hr, media was supplemented either with 100 µM palmitic acid or 100 µM alk-14. 8 hr later cells were harvested using a cell scraper, washed with PBS and frozen at -80 ºC until use. Protein pellets were handled
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identically as for Jurkat cells. Plasmids were as follows: PP1γ C-terminally tagged with EGFP
pEGFP-C1 (Lei Tan and Tarun Kapoor), HSP90α N-terminally His- and C-terminally 3×FLAG
tagged in pcDNA3.1+ (Laura Donlin and Alexander Tarakhovsky) and H3 variants C-terminally
Myc-His tagged in pcDNA4 (Aaron Goldberg and David Allis178).

Western blot analysis
Proteins separated by SDS-PAGE were transferred (50 mM Tris, 40 mM glycine, 0.0375% SDS,
20% MeOH in deionized water, Bio-Rad Trans-Blot Semi-Dry Cell, 20 V, 1 hr) onto a PVDF
membrane. PVDF membrane was incubated with PBST (0.1% Tween-20 in PBS) or PBST with
25 mM Na2S2O4 for 1 hr, and then with PBST containing blocking buffer (5% non-fat dried
milk, 1% BSA and 0.1% Tween-20 in PBS) for 1 hr at 25 °C. The membrane was washed thrice
with PBST, incubated with primary antibodies (manufacture’s recommendations) and horseradish peroxidase-conjugated secondary-antibodies (~1:20,000 in PBST, Jackson ImmunoResearch,
West Grove, PA) and subsequently developed with ECL Western blotting detection reagents
(Amersham).

Streptavidin enrichment of azide/alkyne-modified proteins
Total cell lysates were reacted with azido- or alkynyl-biotinylated detection tags as described
above and protein pellets washed with -80 °C methanol thrice. The protein pellet was resuspended in 4% SDS buffer to which 10 mM EDTA was added to solubilized protein-chelated copper.
The labeled cell lysate was diluted to ~0.5% SDS with 1% Brij 97 in 150 mM NaCl, 50 mM
TEA at pH 7.4 and incubated with streptavidin agarose (0.2 mL slurry/1 mg of protein) for 1 hr
at RT. The streptavidin beads were washed in batch format with 6 times with of 20 column vol39

umes of 2% SDS in PBS, 8 M urea in 250 mM ammonium bicarbonate (ABC), 2.5 M NaCl in
PBS, 0.5 M ABC, 0.25 M ABC and finally 0.05 M ABC. Proteins were eluted from the streptavidin beads with 150 µL of 25 mM sodium dithionite in 0.25% SDS twice and subsequently with
150 µL 25 mM sodium dithionite in 8 M urea twice for 15 min each at RT. The sodium dithionite eluent were combined, exchanged to 50 mM ABC and concentrated to 14 µL on a 10 kDa
MW Centricon. The recovered protein were then diluted with reducing SDS-loading buffer,
heated for 5 min at 95 ºC, separated by SDS-PAGE on 4-20% Tris-glycine gels and stained with
Coomassie blue. Each lane from the gel were cut into 10-24 pieces and digested by previously
described protocols
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. Samples were analyzed on an LTQ-Orbitrap and data analyzed as de-

scribed below. A total of 18 runs were analyzed, composed of 6 negative controls (DMSO), 5
myristic acid analog (az-12/alk-12), 3 palmitic acid analog (alk-14) and 4 stearic acid analog (az15/alk-16).

Liquid chromatography – mass spectrometry (LC-MS) analysis
LC-MS analysis was performed with a Dionex 3000 nano-HPLC coupled to an LTQ-Orbitrap
ion trap mass spectrometer (Thermo Fisher). Peptides were pressure loaded onto a homemade 75
μm diameter, 15 cm C18 reverse phase column and separated with a gradient running from 95%
buffer A (HPLC water with 0.1% formic acid) and 5% buffer B (HPLC grade CH3CN with 0.1%
formic acid) to 55% B over 30 min, next ramping to 95% B over 10 min and holding 95% B for
10 min. One full MS scan (300-2000 MW) was followed by 3 data-dependent scans of the nth
most intense ions with dynamic exclusion enabled. The spray voltage was set to 1.94 kV and the
flow rate through the column was set to 0.25 μL/min.
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Analysis of protein hits from mass spectrometry data
Peptides were identified using SEQUEST version 28 (revision 13) and X!Tandem searched
against the human IPI database version 3.50 (74,016 entries); searches were also run against the
same database containing a randomized version of all sequences (148,032 entries). Mass tolerances were set at 10 ppm precursor mass and 1 Da fragment mass. Cysteines were considered
constantly modified by carboxyamidomethylation. Allowable variable modifications in SEQUEST included oxidation on methionine and tryptophan, deamidation of asparagine and glutamine, and acetylation on the N-terminus and lysine; lysine acetylation was rarely observed except for histones. Allowable variable modifications in X!Tandem were the same with the addition of amino acid cyclization with an N-terminal glutamine or iodoacetamide-capped cysteine (NH3), or glutamic acid (-OH) resulting in N-terminal pyrrolidone carboxylic acids.

SEQUEST and X!Tandem search results were imported into Scaffold for PeptideProphet filtering. To generate a large space for PeptideProphet to model possible incorrect identifications,
peptides were initially searched against a database generated with KRNLH trypsin specificity allowing 5 missed cleavages. Only peptides judged by PeptideProphet to have a ≥95% likelihood
of correct assignment were accepted. PeptideProphet probabilities are a combined function of
both Xcorr and ∆cn and, in particular with high mass accuracy data, some spurious peptide identifications received a high probability due to a very high ∆cn despite a low Xcorr (i.e. < 1). These
spurious hits represent, for example, environmental contaminants which match very well in mass
to one possible peptide, but which exhibit minimal fragmentation. Thus, in addition to the primary PeptideProphet probability filter, all peptide identifications with an Xcorr ≤1, ∆cn ≤ 0.02 or E
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≤ 1 were deemed unacceptable. With these filter criteria, SEQUEST Xcorr averaged ~3.1 and
X!Tandem E ~2.9.

After this peptide-level filter, proteins were deemed identified if they matched two or more tryptic peptides with a maximum of three missed cleavages. After this, high probability semi- and
non-tryptic peptides from the initial broad search were accepted as additional sequence coverage.
Only proteins identified in more than two runs are listed. This analysis was also performed with
a randomized database appended to the real sequences. No randomized proteins were present after these filter criteria. Proteins were allowed to share homologous peptides and redundant proteins were identified similar to the procedure described by Kearney et al.
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. Protein accession

numbers matching a subset of peptides were determined and are indicated but not counted in the
number of identified proteins. For example, if protein P1 is matched by peptides A, B and C and
protein P2 is matched by A and B, P2 is listed as a subhit and not counted. Likewise, in the case
that two accession numbers match exactly the same peptides, the first (lowest numerical) IPI accession number is reported and the others are listed and not counted. Note that all accession
numbers matching a distinct set of peptides are listed. For example, if protein P3 is matched by
peptides D, E and F; protein P4 is matched by peptides D, E and G, and protein P5 is matched by
peptides D, F and G, then P3, P4 and P5 will all be listed. In these cases, accession numbers are
highlighted with an asterisk. Appendix Table 7 lists the peptides associated with each IPI accession number with shared peptides underlined and Appendix Table 8 lists all IPI numbers which
match to a particular peptide.
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Independent MS runs were normalized by determining the analog with the most accepted and
identified peptides (“counts”) in each run and normalizing those maximum counts to a constant
value. This normalization constant was then applied to the counts for all proteins of all other analogs; averaged normalized counts were calculated for each protein across all runs. The first two
myristic acid analog experiments were handled slightly differently because these experiments
lacked other analogs. In this case, the average of the normalized myristic acid signal from all experiments except the first two was first calculated and a constant was calculated to bring the total
maximum signal of myristic analog counts to this normalized average. To allow presentation
across different abundances, these averaged, normalized spectral counts were presented as percentage of maximum, with full red representing 100% of maximal signal strength and full white
representing 0%. Figure 10 also shows the total positive abundance and total abundance normalized for protein molecular weight. For the normalized abundance, spectral counts were scaled
such that: 1) the total number of counts remains the same; and 2) counts are linearly scaled by
the molecular weight of the proteins. Thus, if two proteins, P1 at 50 kDa and P2 at 100 kDa,
were both observed to have 10 spectral counts, the adjusted abundance of P1 would be 13.3 and
P2 would be 6.7 (total = 20 and P1 abundance twice that of P2).

Bioinformatic analysis of protein identifications
For prediction of N-myristoylation and S-palmitoylation, MYRbase and CSS-Palm were used respectively. In the case of N-myristoylation, three levels of confidence in order of decreasing certainty were respectively given the numerical value (red shading) of 100%, 67% and 33%. Confidence levels of 100% and 67% correspond respectively to the “RELIABLE” and “TWILIGHT
ZONE” predictions of MYRbase. The lowest confidence level reflects no prediction of myristoy43

lation by MYRbase, but the presence of an N-terminal glycine or methionine-glycine. Likewise,
protein sequences predicted to be palmitoylated by the CSS-Palm set at the “high,” “medium,”
and “low” cutoffs were assigned S-palmitoylation prediction confidence values of 100%, 67%
and 33% respectively. For comparison of our data with published data sets, three separate approaches were required for each published set. For comparative analysis of Martin and Cravatt
data, both IPI numbers and gene symbols were compared. High confidence proteins were assigned 100% confidence and medium confidence proteins 50% coloration. In all comparisons,
caution must be exercised as each IPI number may have more than one gene symbol and likewise
one gene symbol may exist for multiple IPI numbers. Due to the difference in species, all comparisons involving the Davis data were performed solely at the level of gene symbol (protein
homology). Gene symbols for all accession numbers from both datasets were taken from current
database entries; in the cases where gene symbols had not yet been entered, they were determined by BLAST. Gene symbols were compared and the confidence for Davis data calculated as
follows: for both the cultured neuron and rat synaptosomal fractions, confidences of 50%, 33%
and 16.7% were assigned to high, medium and low confidence protein identifications as classified by Davis and coworkers. The confidences for the cultured neuron and rat synaptosomal fractions were then summed, so that a protein found in both and characterized at a high confidence
received a total of 100% confidence, while a protein found once in a high confidence and once in
a medium confidence would receive 83% red shading. For Zacharias data, all reported peptides
were searched against the human IPI database; these IPI numbers were compared to the data
here. Those peptides observed more than once were assigned 100% confidence, while those observed once were assigned 50% confidence. Freeman data was treated like Cravatt with high
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confidence proteins assigned 100% coloration and medium confidence identifications assigned
50%.

Cholesterol imaging
Az-chol181, az-1594, TBTA and alkyne-rhodamine94 were prepared as previously described. M-12
cells were kindly provided by Dr. Daniel Ory (Washington University in St. Louis, Saint Louis,
MO). 293T-Shh cells were obtained from American Type Culture Collection (cat. no. CRL2782, Manassas, VA). Cell-culture grade cholesterol (C3045) and palmitic acid (P5585), filipin
(F4767), cyanogen bromide activated Sepharose 4B fast flow beads (C9142), FITC-conjugated
cholera toxin B (C1655) muristerone A (M7888), paraformaldehyde (158127), glutaraldehyde
(G5882), cell culture grade DMSO (D2438), ultrapure benzonase (E8263) and methyl-βcyclodextran (C4555) and all buffer reagents were purchased from Sigma (St. Louis, MO).
SYTO 11 (S7573), DAPI (D3571), Zeocin (R250), ProLong Gold and Gibco cell culture media
were purchased from Invitrogen (Carlsbad, CA). Sera were obtained from Omega Scientific
(Tarzana, CA). 20% and 4 – 20% Tris-HCl Criterion gels were from Biorad (Hercules, CA). Antibodies against calreticulin (1:500, ab2907, Abcam, Cambridge, MA), LAMP-1 (1:500,
ab24170, Abcam), EEA1 (1:100, 2411, Cell Signaling Technology, Danvers, MA), and golgin97 (1:100, ab33701, Abcam) were used. Anti-N-Shh clone 5E1182 was obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA). Polyclonal goat antimouse Shh (AF464) was purchased from R&D Systems (Minneapolis, MN). HRP conjugated
anti-goat secondary (705-035-147) was obtained from Jackson ImmunoResearch Laboratories
(West Grove, PA).
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Cell culture, metabolic labeling and Shh induction
293T and 293T-Shh cells were cultured in high glucose DMEM with glutamine containing 10%
fetal bovine serum (FBS), 100 U/mL penicillin and 100 µg/mL streptomycin. Both cell lines
were grown to 30 to 40% confluency at which time medium was changed, replacing FBS with
10% delipidated charcoal-dextran filtered fetal bovine serum (CDFBS). 293T-Shh cells were selected by the inclusion of Zeocin (360 µg/ml), and G418 (400 µg/ml). CHO and M12 cells were
cultured in F-12 with 10% delipidated CDFBS, 100 U/mL penicillin and 100 µg/mL streptomycin. Cells were maintained in a humidified 37 ºC incubator with 5% CO2. For microscopy, cells
were cultured on glass coverslips in 24-well tissue culture plates.

Stock solutions of 50 mM cholesterol and az-chol were prepared in absolute ethanol. 50 mM
stocks of palmitic acid and az-15 were kept in cell culture grade DMSO. All stocks were stored
at –20 C. For all experiments, lipids were added into warm culture media containing 10%
CDFBS and placed in a sonication bath for 30 min – 1 hr. The temperature of the culture media
and bath water was continually monitored; sonication was paused above 40 ºC to allow for cooling. Metabolic labeling of CHO and M12 cells for visualization was done at 50 µM cholesterol
or az-chol for ~16 hrs (overnight). 293T and 293T-Shh cells labeled identically except at 100
µM; palmitic acid or az-15 was applied at 12.5 µM for 8 hr. 293T-Shh cells were grown to ~90%
confluency and induced with 1 µM muristerone A from a 10 mM stock in absolute ethanol for 8
hrs prior to addition of medium containing cholesterol or az-chol; Zeocin and G418 were eliminated from induction media. 8 hrs later, palmitic acid or az-15 was added. 293T and 293T-Shh
cells were harvested 8 hr later after three PBS washes and prepared as described below.
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Cell lysate preparation, CuAAC labeling and in-gel fluorescence imaging
For analysis by SDS-PAGE, 293T and 293T-Shh cells were lysed in hypotonic buffer (5 mM
TEA, pH 7.4, 5 mM MgCl2, 10 mM PMSF, Roche Complete EDTA-free protease inhibitors at
20x) to which benzonase at 1000 U/mL had been added. Cells were intermittently vortexed and
sonicated for 30 min at 4 ºC after which an equal volume of 8% SDS, 300 mM NaCl, 100 mM
TEA pH 7.4 was added. Cells were again sonicated and incubated for 10 min at RT; at this point
the solution was clear. The supernatant was centrifuged at 10,000 g, 0 ºC for 30 min and the supernatant removed and stored at -80 ºC until future use. Cell lysis for immunoprecipitation was
identical with the exception that 8% SDS was replaced with 2% Brij-97 for a final lysate in 1%
Brij-97, ~50 mM TEA and ~150 mM NaCl; a pellet was present with Brij lysis. Protein concentration of cell lysates was determined by a BCA assay using 2 mg/mL BSA as a standard.

Cell lysates were labeled in 4% SDS, 150 mM NaCl and 50 mM TEA with protease inhibitors at
1 mg/mL. Protein was reacted for 2 hr at RT with 100 μM alk-Rho from a 10 mM DMSO stock
solution, 1 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) from a 50 mM freshly prepared aqueous stock solution, 100 μM tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine
(TBTA) from a 25 mM DMSO stock and 1 mM CuSO4 from a 50 mM freshly prepared aqueous
stock solution. The reactions were terminated by the addition of 8 volumes of -20 °C methanol
and placed at -20 °C overnight. Precipitated proteins were pelleted the next day by centrifugation
(18,000 g, 10 min, at 0 °C and the supernatant discarded. Protein pellets were air dried for 10
min, resuspended in 35 μL of resuspension buffer (4% SDS, 50 mM triethanolamine pH 7.4, 150
mM NaCl), diluted with 12.5 μL 4X reducing SDS-loading buffer (40% glycerol, 200 mM TrisHCl pH 6.8, 8% SDS, 0.4% bromophenol blue) and 2.5 μL 2-mercaptoethanol, heated for 5 min
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at 95 ºC and ~20 μg of protein was loaded per gel lane for separation by SDS-PAGE (10% or 420% Bio-Rad Criterion Tris-HCl gel). Protein gels were then visualized by in-gel fluorescence
scanning with an Amersham Biosciences Typhoon 9400 variable mode imager (excitation 532
nm, 580 nm filter, 30 nm band-pass).

Immunoprecipitation and Western blotting
Ascites fluid containing anti-N-Shh monoclonal antibody 5E1 was buffer exchanged against water with a Pierce Zeba column and coupled as per manufacturer’s instructions to CNBr-activated
Sepharose 4B. 750 µg of induced 293T-Shh Brij lysate was mixed with 15 µL 5E1 beads and incubated for 1 hr with agitation at RT. Beads were washed 3x with Brij-97 buffer and resuspended in 28 µL of 4% SDS buffer containing all CuAAC reagents. Beads were reacted for 1 hr at RT
after which 10 µL of 4X LDS sample buffer and 2 µL 2-mercaptoethanol were added. The reaction was sonicated, supernatant removed and analyzed by SDS-PAGE. 19 µL was applied to a 4
– 20% tris-HCl gel for fluorescence scanning as described above; 19 µL was applied to a 20%
tris-HCl gel for Western blotting. Blots were transferred (50 mM Tris, 40 mM glycine, 0.0375%
SDS, 20% MeOH in deionized water, Bio-Rad Trans-Blot Semi-Dry Cell, 20 V, 40 min) onto a
PVDF membrane and the membrane was blocked in 0.1% Tween-20 in PBS (PBST) with 5%
non-fat dried milk and 1% BSA for 1 hr at 25 °C. After a short rinse, the blot was incubated with
goat anti-N-Shh at 1:500 in 5% casein, 1% BSA in PBST, washed three times and incubated with
horseradish peroxidase-conjugated secondary-antibodies (~1:15,000 in PBST). Blot was subsequently developed with ECL Western blotting detection reagents (Amersham).
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Cellular az-chol labeling and filipin staining
Cells grown on coverslips were washed three times with PBS prior to fixation. Cells to which
only chemical techniques were applied were fixed in 1% glutaraldehyde and 4% PFA in PBS for
1 hr; fixation for antibody staining was with 4% PFA for 15 min at RT. Both fixations were followed by 3 x 5 min PBS washes. Cells were subsequently blocked for 1 hr in 20% CDFBS at RT
followed by 3 x 5 min PBS washes. Samples intended for antibody analysis were permeabilized
with 1% tween-20 in PBS for 10 min at RT. Alternatively, cholesterol was depleted by the addition of -20 ºC HPLC grade methanol (JT Baker) for 10 min or 10 mM MβCD in PBS for 10 min.
In both cases, samples were again washed 3 x 5 min PBS. Primary antibodies were applied in
PBST for 1 hr followed by 3 x 5 min PBST washes. Fluorescent conjugated secondary antibodies
diluted 1:750 in PBST were applied for 45 min followed by the same washing. For all samples,
filipin was prepared at 25 µg/mL in PBS; reagents for CuAAC were added to this solution at the
same concentrations as with labeling of cell lysates and samples were labeled for 1 hr. Samples
were then washed 3 x 5 min in PBST containing 5 mM EDTA, followed by 5 min incubation in
1:40,000 SYTO 11 and 2 x 5 min PBS washes. Cells were mounted in Prolong Gold and imaged
as described below. All negative controls were handled identically and in parallel with az-chol
labeled samples.

In vivo az-chol labeling and tissue sectioning
Mice work was performed according to approved Memorial Sloan-Kettering animal protocols.
Swiss-Webster mice pregnant with E12.5 embryos were anesthetized with isoflurane. In the supine position, a 4 cm vertical incision was made from below the ribcage to middle of the intestines. The uterine horns were carefully laid on a sterile field and 1 – 2 µL of 50 mM az-chol
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stock mixed with 1 – 1.5 µL cell culture grade DMSO was injected directly into the lateral ventricle of a single embryo using a pulled glass capillary needle. Upon completion, the uterus was
returned to the abdominal cavity, the skin and muscle were sutured closed and the closure was
reinforced with veterinary staples. The analgesic buprenorphine (Buprenex™) was administered
at a dose of 0.1 mg/kg and the mouse was removed from the anesthetic and placed on a warming
pad for recuperation. Once awoken, the mouse was returned to its cage for 6 hours for analog incorporation. After incorporation, the embryos were collected and decapitated. The heads were
immediately fixed in 4% paraformaldehyde-PBS for 20 minutes, cryoprotected in 30% sucrose
in PBS and embedded in OCT for cryo-sectioning. 14 µm sections were cut on a Leica3050 S
cryostat; mounted sections were stored at -20 ºC until use. Tissues were mounted and fixed sections were hydrated with 3 x 5 min PBS, blocked as described above and washed again with
PBST. CuAAC labeling was performed as described above with the exception that filipin was
not included. After washing excess CuAAC reagents, samples were incubated with DAPI (5
mg/mL solution diluted 1:40,000 in PBS) for 15 min followed by identical rinsing and mounting.
All negative controls were handled identically and in parallel with az-chol labeled samples.

Fluorescence microscopy
All cell culture samples and high magnification brain images were obtained on a DeltaVision
Applied Precision Image Restoration Inverted Olympus IX-70 microscope using a 60x oil objective. Images were deconvolved in SoftWoRx (Applied Precision / DeltaVision); identical image
display settings were applied to positive and negative samples. Low magnification (10x) fluorescent images were collected on a Zeiss Axio Observer.Z1 microscope equipped with Axiovision
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software. Pearson’s coefficients were determined in ImageJ with the JACoP (Just Another Colocalization

Plugin)

plugin

(Fabrice
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PROTEIN ACYLATION IN MAMMALIAN CELLS

Introduction
The diversity of fatty-acylated proteins and their mechanisms of regulations are not completely
understood5. Prediction algorithms such as Myrbase183 and CSS-Palm22 provide useful bioinformatic tools for the analysis of candidate fatty-acylated proteins based on previously observed
modification motifs, but require experimental validation and offer no insight into the posttranscriptional mechanisms of fatty-acylation. For example, alternative splicing of mRNA transcripts may yield substrates for N-myristoylation as in the case of the p35 isoform of OCA-B, a
transcription factor required for late-stage B cell development14,15. Alternatively, protein fattyacylation may be altered during cellular regulation. During programmed cell death, the apoptosis
effector tBid is post-translationally N-myristoylated after proteolytic cleavage by the cysteine
protease caspase-3, which targets tBid to mitochondrial membranes during apoptosis

12,13

. Dis-

secting the regulatory mechanisms of S-palmitoylation in mammals also presents a significant
challenge as ~23 DHHC-PATs have been identified in human and mouse genomes with overlapping substrate specificities21. Moreover, the functions of fatty-acylated proteins can be regulated
by other post-translational modifications (PTMs) such as phosphorylation, as exemplified by
studies on MARCKS7, c-Abl kinase8,9 and potassium channels10. Robust experimental methods
are therefore needed to fully appreciate the diversity and functional roles of protein fattyacylation.
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Figure 6 Protein fatty-acylation and its analysis with bioorthogonal chemical reporters. A)
Chemical modification of fatty-acylated proteins. Palmitoylation is heterogeneous in length and
saturation; only palmitic acid is shown. B) Schematic for proteomic analysis of fatty-acylated
proteins with chemical reporters using cleavable affinity tags. Jurkat T cells were metabolically
labeled with DMSO control (-) or alk-FAs (20 µM myristic analogs, 100 µM all other analogs;
6-8 hr). Total cell lysates were then subjected to click chemistry reaction with az-azo-biotin (100
µM), small molecule removal, affinity-enrichment with streptavidin-beads, selective elution
from beads with sodium dithionite (Na2S2O4, 25 mM, 1 hr) and separation by SDS-PAGE. Selectively recovered proteins were analyzed by immunoblot using specific antibodies or stained with
Coomassie blue and processed for mass spectrometry-based protein identification. X = NH (Nmyristoylation) or S (S-palmitoylation). C) Profile of alkynyl-fatty acid-labeled proteins in total
cell lysates visualized by click chemistry reaction with az-Rho/in-gel fluorescence scanning (left
panel) or with az-azo-biotin, streptavidin enrichment, Na2S2O4 elution and Coomassie blue staining (right panel). Coomassie staining of total cell lysates from each sample (-, alk-12, alk-14,
alk-16) demonstrates comparable amounts of protein loading for both fluorescence imaging and
affinity enrichment of labeled proteins (middle panel). Similarities such as the ~20kDa band
marked with an asterisks are apparent between fluorescence and Coomassie detection.
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Two chemical methods have been developed to overcome the limitations of radiolabeled fatty
acids for the detection and identification of fatty-acylated proteins184. The acyl-biotin exchange
(ABE) protocol developed by Drisdel and Green exploits the differential sensitivity of thioesters
to hydroxylamine (NH2OH) for selective biotinylation of S-acylated proteins and non-radioactive
visualization by streptavidin blot185 as well as enrichment of S-acylated peptides or proteins for
proteomic analysis by mass spectrometry186-189. The global profiling of S-palmitoylation in budding yeast with ABE identified several new S-palmitoylated proteins and highlighted the differential and overlapping substrate specificities of the DHHC-PATs186,187. The application of ABE
to neurons revealed isoform-specific S-palmitoylation of the GTPase Cdc42 in the brain as well
as many new candidate S-palmitoylated proteins188. Enrichment of S-acylated peptides from
mammalian cells by ABE has also expanded the list of S-palmitoylated proteins and sites of Sacylation189,190. Alternatively, we93,99,191 and others95-98,121,122,192 have developed fatty acid chemical reporters of protein fatty-acylation that enable rapid non-radioactive detection of fattyacylated proteins from mammalian cells using bioorthogonal ligation methods109 such as the
Staudinger ligation or CuI-catalyzed [3+2] azide-alkyne cycloaddition (CuAAC)184,193 (Figure 6).
Metabolic labeling of mammalian cells with azido/alkynyl-fatty acid (az/alk-FA) chemical reporters followed by reaction of azide/alkyne-modified proteins with biotinylated or fluorescent
detection tags allows the visualization of fatty-acylated proteins by streptavidin blot93,95-99,121 or
in-gel fluorescence122,191,192,194, respectively. The direct comparison of various detection modes
has demonstrated that metabolic labeling of cells with alkynyl-fatty acids (alk-FAs) in combination with CuAAC and in-gel fluorescence scanning affords the optimal method for the visualization of protein fatty-acylation191. Indeed, the analysis of various mammalian cell lines with fatty
acid chemical reporters and CuAAC/in-gel fluorescence scanning revealed unique and diverse
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profiles of fatty-acylated proteins191. Large-scale profiling of S-acylated proteins in Jurkat T cell
membrane fractions with an alkynyl-palmitate reporter (17-octadecynoic acid abbreviated 17ODYA or alk-16) by Martin and Cravatt using CuAAC labeling/enrichment methods, on-bead
proteolysis and multidimensional protein identification technology (MudPIT) recovered many
new candidate S-palmitoylated proteins and identified a family of serine hydrolases that is targeted to membranes by palmitoylation122. Herein, we describe the proteomic analysis of fattyacylated proteins in mammalian cells in which we employ a series of fatty acid chemical reporters representing myristic to stearic acids (Figure 6). This survey is unbiased in that all cellular
proteins were solubilized and analyzed; no fractionation such as membrane preparations was
used. Our studies of total cell lysates from Jurkat T cells have revealed known and novel candidate fatty-acylated proteins, including nuclear components such as S-acylated histone H3 variants.
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Results

Characterization of cleavable affinity reagents for CuAAC-based proteomics
To facilitate the identification of azide- and alkyne-modified proteins targeted by bioorthogonal
chemical reporters, we utilized clickable and cleavable affinity reagents for CuAAC, streptavidin
enrichment and selective elution of recovered polypeptides for proteomic analysis (Figure 6).
While the biotin-avidin interaction provides an excellent system for selective detection and retrieval of biomolecules, the high affinity binding (~KD 10-15 M) of this interaction makes quantitative elution of biotinylated proteins from streptavidin beads challenging. Indeed, selective elution strategies using protease-135,195,196, pH-197-199, redox-200-202 or photo-cleavable203-205 linkers
have been described to recover peptides or proteins following streptavidin enrichment. We employed the azobenzene linker as this functional group can be efficiently cleaved by mild reduction with sodium dithionite200-202 (Na2S2O4, see

Figure 7) and stable to click chemistry conditions177,206. Exposure of azido-azo-biotin previously
generated by our laboratory177 to various reducing agents demonstrated the azobenzene linkage
was stable to reducing agents such as TCEP (tris(2-carboxyethyl)phosphine), but readily cleaved
with 25 mM Na2S2O4 (Figure 8) These experiments demonstrated that the cleavable affinity tags,
alk-azo-biotin and az-azo-biotin, are compatible with click chemistry (1 mM TCEP) and reductive alkylation (10 mM TCEP) reaction conditions used for proteomic studies. We have previously utilized az-azo-biotin for CuAAC-based proteomic analysis of acetylated proteins in
mammalian cells177 and lipoproteins in bacteria207. For this study, alk-azo-biotin was also synthe-
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sized to explore CuAAC, enrichment and identification of proteins targeted by azido-fatty acids
(Figure 9).

Figure 7 Mechanism of azo cleavage by sodium dithionite. The first step can proceed in either a
stepwise or concerted fashion.
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Figure 8 Analysis of azido-biotinylated cleavable linker (az-azo-biotin) under reductive conditions. A) Structures of reduced cleavable linkers and their mass to charge ratios. B) Linker at 100
µM was exposed to the different reducing conditions of panel B in 50 mM TEA, 150 mM NaCl
at pH 7.4. After reduction for 1 hr, reactions were stopped by reverse-phase solid phase extraction, washed, concentrated and analyzed by HPLC. Only 25 mM Na2S2O4 was able to cleave the
azo-benzene bond. Note the reduction of the terminal
azide to an amine (NH2-azo-biotin) cannot
64
happen after the click reaction.

Figure 9 A) Azido-fatty acids. B) Clickable rhodamine dyes. C) Synthesis of alk-azo-biotin: (a)
NaNO2, 6M HCl, 4-aminobenzoic acid. (b) 6-heptynoic-NHS ester, Et3N, THF, 30% yield over
two steps. (c) DCC, N-hydroxysuccinimide (NHS), THF, 70%. (d) biotin-PEG-NH2, DMF, 24%
yield.
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Proteomic analysis of fatty-acylated proteins in mammalian cells
To identify proteins targeted by fatty acid reporters, az-FA- and alk-FA-labeled Jurkat T cell
lysates were reacted with the alk-azo-biotin and az-azo-biotin, respectively, incubated with
streptavidin beads and extensively washed with denaturing buffers to remove non-specifically
bound proteins (Figure 6B). Proteins that remained bound to streptavidin beads were selective
eluted with 25 mM Na2S2O4, separated by SDS-PAGE and analyzed by Coomassie blue staining
or immunoblotted for specific proteins (Figure 6B). Coomassie blue staining of the polypeptides
selectively eluted from streptavidin beads revealed significantly greater amounts of proteins
recovered from alk-FA and az-FA-labeled cell lysates compared to control (-) (Figure 6C, Figure
10B, D and E). A fraction of the cell lysates analyzed in parallel demonstrated equal levels of
input material (Figure 6C). The profile of selectively recovered polypeptides roughly mirrors the
fatty-acylated proteins visualized by CuAAC/in-gel fluorescence scanning although the modes of
protein detection are different (Figure 6C). For example, the ~20 kDa polypeptide that is
preferentially labeled in az-12/alk-12 cell lysates by in-gel fluorescence is also apparent by the
Coomassie blue-stained gel of selectively recovered proteins from streptavidin enrichment and
Na2S2O4 elution (Figure 6C, Figure 10C). Western blot analysis of az-FA-labeled samples for
known fatty-acylated proteins in Jurkat T cells such as Lck93 and Tfr208,209 demonstrated the
specificity of the CuAAC, streptavidin enrichment and Na2S2O4 elution protocol (Figure 10C).
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Figure 10 Enrichment of azide/alkyne-modified proteins targeted by fatty acid chemical reporters. A) In-gel fluorescence profile of azido-fatty acid labeled proteins from Jurkat T cells after
CuAAC reaction with alk-Rho. B) Coomassie staining of azido-fatty acid labeled proteins following CuAAC reaction with alk-azo-biotin, streptavidin enrichment, sodium dithionite elution
and SDS-PAGE. C) Validation of azido-fatty acid recovered proteins by western blot. D) Preliminary runs of az-12 labeled proteins following CuAAC reaction with alk-azo-biotin, streptavidin
enrichment, sodium dithionite elution and SDS-PAGE. E) Enrichment of alk-FA-modified proteins after CuAAC labeling with az-azo-biotin, streptavidin enrichment, sodium dithionite elution and SDS-PAGE.
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Figure 11 Proteins identified from Jurkat T cells metabolically labeled with click-chemistry
compatible fatty acids of different chain lengths (myristic acid = az- and alk-12), (palmitic = alk14), (stearic = az-15 and alk-16) or DMSO carrier control (-); high confidence only (≥ 5 identifications with 5-fold enrichment over DMSO control). Proteins with the same gene symbol but
different IPI numbers are marked with an asterisks (*). Under experimental, intensity of heat
map coloration represents normalized peptide counts for each protein hit averaged over 6 independent proteomic experiments. Proteins are clustered by their propensity to be modified from
short to long chain fatty acids and assigned to seven groups: I: modified mainly by myristic acid;
II: modified mainly by myristic and palmitic acids; III: myristic and stearic acids; IV: palmitic
acid; V: palmitic and stearic acids; VI: palmitic acid; VII: myristic, palmitic and stearic acids.
Group VIII are proteins enriched in the negative control (marked with a dagger (†); counts are
negatives in excess of positive). Proteins labeled by all fatty acids are sorted by the correlation
between their averaged normalized signal strengths and the physical length of the fatty acid
chains. Intensity of red in prediction and in comparative analysis to other reported experimental
datasets represents confidence of prediction or identification, respectively, given criteria set by
each study. N-terminal myristoylation was predicted by MYRbase. S-palmitoylated was predicted by CSS-Palm. In comparative analysis, a black box means a protein was identifiable by our
data which matched an accession number published in other data sets, but which differs from the
reported accession number of this figure due to additional sequence coverage or uncertainty in
peptide-level identification. A grey box represents the same situation, except that 1) both an unlisted, interpretable accession number and the exact accession number listed match published reports; and 2) the confidence of the unlisted number is higher than the accession number listed
here. In that case, the higher confidence of the unlisted accession number is shown. The total
number of peptide counts in excess of any negative (log scale) and the number of times the protein was identified. Nearly four orders of magnitude are spanned (11 – 8075 raw counts)
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Figure 11 cont.
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Having confirmed the specificity and low background of CuAAC and affinity enrichment
methods, we proceeded with the large-scale identification of proteins targeted by the az/alk-FAs
in Jurkat T cells. Az/alk-FA-labeled and control total cell lysates were reacted with clickable and
cleavable affinity reagents (alk-azo-biotin, az-azo-biotin, respectively), purified by streptavidin
enrichment and sodium dithionite elution protocol described above (Figure 6B). The Coomassie
blue-stained gels of the recovered proteins were then processed using standard protocols for gelbased proteomics and analyzed by nano-reverse-phase liquid chromatography and tandem mass
spectrometry for protein identification using the LTQ-Orbitrap. Two initial proteomic runs were
performed with az-12-labeled cell lysates, followed by four additional experiments using az/alkFAs of different chain length (Figure 6C). Tandem MS/MS analysis of tryptic peptides followed
by database searches using Sequest and X!Tandem with standard peptide hit filter criteria and
two-unique peptide cut-off for protein identification revealed many known fatty-acylated
proteins and new candidate fatty-acylated proteins not present in or significantly enriched
compared to negative controls (Appendix Tables 1 and 2). Preliminary analysis of proteins
selectively recovered from az-12 and alk-12-labeled cell lysates yielded a similar composition of
protein hits (Appendix Tables 1, 2 and 6), which is consistent with our previous experiments that
demonstrated az-FA and alk-FA both function as efficient chemical reporters of protein fattyacylation on known proteins such as Lck, LAT and Ras191. Proteomic data based on peptide
spectral counts from negative control lanes (-, n = 6), myristic (az-12, n = 3 and alk-12, n = 3),
palmitic (alk-14, n = 3) and stearic (az-15, n = 1, alk-16, n = 3) acid analogs were therefore
combined and collated to evaluate proteins that were selectively labeled with fatty acid chemical
reporters and separated into high and medium confidence groups (Appendix Tables 1 and 2). The
normalized peptide spectral counts from the protein hits were represented in a heat map for
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comparative analysis (Figure 11). A total of 178 proteins were identified > 5 times in az/alk-FA
labeled cells with at least > 5-fold enrichment of normalized peptide counts compared to
negative controls were sorted into the high confidence group; only two proteins were inversely
enriched in the negative controls (Figure 11). Another 183 proteins in the medium confidence list
were selectively identified at least twice in az/alk-FA labeled cells and yielded at least 3-fold
enrichment of normalized peptide counts compared to negative control (Appendix Table 2).
Direct comparison of selectively identified protein hits from two proteomic runs of alk-16
performed in parallel suggested that the high confidence protein hits are reproducibly recovered
from independent experiments. Many known candidate fatty-acylated proteins were recovered
from our proteomic studies. For example, N-myristoylated proteins such as ADP-ribosylation
factors (ARF1, ARF4 and ARF5), Src-family kinase Lck, protein phosphatase 1G (PPM1G), Gprotein subunits (Gi, Gk and Go) and myristoylated, alanine-rich protein kinase C substrate
(MARCKS), as well as S-palmitoylated proteins including the transferrin receptor (TfR),
calnexin (CANX), N-Ras, and tetraspanins (CD81 and CD82) were identified from az/alk-FA
labeled Jurkat T cells in the high confidence group (Figure 11).
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Figure 12 Immunoblot analysis of selectively recovered proteins. A) Known fatty-acylated proteins. B) New candidate proteins. C) Robust enrichment of endogenously fatty-acylated HSP90.
D) In-gel fluorescence detection of immunoprecipitated HSP90 metabolically labeled with alkynyl-fatty acid after CuAAC reaction with az-Rho.
To evaluate the specific recovery of protein hits from az/alk-FA-labeled cell lysates in our
proteomic dataset, total cell lysates and Na2S2O4 eluents were analyzed by Western blot.
Immunoblot analysis for known fatty-acylated proteins such as transferrin receptor (TfR), Lck,
calnexin (CANX), linker-associated with T cell activation (LAT), N-Ras, and ADF-ribosylation
factors (ARFs) confirmed mass spectrometric identification and specific retrieval from az/alkFA-labeled cell lysates (Figure 12A). We also evaluated other proteins from our proteomic
dataset that have not been previously confirmed to be fatty-acylated. For example, Western blot
analysis for heat shock proteins (HSP90, GRP94), phosphatase subunits (PP1β, PP1γ) and other
proteins (Ran, histone (H3), coronin-1A (COR1A), 14-3-3, transitional endoplasmic reticulum
ATPase (p97/VCP) confirmed their selective retrieval and identification by mass spectrometry
(Figure 12B). The analysis of fatty-acylated protein levels in total cell lysates compared to the
amount of protein recovered from affinity enrichment affords a qualitative measure of how much
68

protein is metabolically labeled with fatty acid reporters. N-myristoylated proteins such as Lck
and ARFs appeared to be recovered in significant amounts compared to total cell lysates (Figure
12A). Interestingly, the S-palmitoylated protein LAT was robustly enriched in Na2S2O4 elutions
compared to cell lysates (Figure 12A). In contrast, relatively low amounts of HSP90, GRP94,
PP1β, PP1γ and Ran are recovered from fatty acid reporter labeling and affinity enrichment
compared to cell lysates (Figure 12B), indicating a large dynamic range of fatty-acylation
stoichiometry; the robust signal for known fatty-acylated proteins is likely a factor in their
previous discovery. As expected, increasing the amount of alk-FA/CuAAC enriched proteins
relative to total cell lysate demonstrated more robust relative signal intensity of alk-FA labeled
endogenous HSP90 (Figure 12C). Fatty-acylation of endogenous HSP90 was also confirmed
following alk-16 labeling of Jurkat cells, immunoprecipitation, CuAAC reaction with az-Rho
and in-gel fluorescence scanning (Figure 12D).

To further validate mass spectrometric and antibody detection of low level fatty-acylation of
proteins and clarify highly homologous histone H3 variants, we analyzed the fatty acid reporter
labeling and enrichment of overexpressed constructs bearing epitope-tags (Figure 13). These
experiments employed alk-14, as this analog yielded the broadest labeling amongst the candidate
proteins analyzed. The results for HSP90, PP1γ and the histone H3 variants recapitulated the data
obtained for endogenously expressed proteins and revealed similar labeling and enrichment of
histones H3.1, H3.2 and H3.3. Because all histone H3 variants share a single conserved cysteine
at position 110, we analyzed alk-14 labeling and enrichment of epitope-tagged H3.2 and C110A
mutant as well as endogenous calnexin in parallel as a positive control (Figure 13B). Although
calnexin signal was similar for both alk-14 labeled samples, H3.2 labeling was completely
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abrogated in C110A construct, indicating that Cys110 is the site of H3.2 fatty-acylation. These
results highlight the utility of bioorthogonal chemical reporters for large-scale profiling of fattyacylated and identification of novel fatty-acylated proteins from fully solubilized cell lysates.

Figure 13 Further validation of candidate proteins. A) Validation of Hsp90, PP1γ and histone H3
variants by transfection with tagged constructs. B) Identification of Cys110 in histone H3.2 as
the site of S-palmitoylation. While endogenous calnexin is similarly enriched and detected, all
recovery of H3.2 is lost with a C110A mutation. C) Isolation of histone H3 by immunoprecipitation and in-gel fluorescence detects fatty-acylation directly.
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Figure 14 Overlap of fatty-acylated protein studies and analysis of selectively recovered proteins
from this study. A) Comparative analysis of high and medium confidence protein hits recovered
CuAAC studies by gene symbol and IPI numbers. For IPI numbers, parentheses represent values
including possible interpretations of peptide identification not reported in Figure 2 or Supplementary Figure 4. B) Overlap of this study with acyl-biotin exchange studies. C) Overlap of all
CuAAC studies and ABE studies by gene symbol. D) Subcellular distribution of high confidence
protein hits based upon WoLF PSORT prediction algorithm. E) Subcellular distribution of high
confidence protein hits based upon biochemical fraction studies of Jurkat T cells. F) Biological
pathway analysis of high confidence protein hits.
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Figure 15 A) Gene symbol overlap of all studies, high and medium confidence. B) Full overlap
of high and medium confidences, all studies. C) Gene symbol overlap of high confidence only
from all studies; in parentheses, high confidence of this study versus both high and medium confidence of other studies. D) Frequency of gene symbol observation from all studies of fattyacylated proteins. E) Percentage of overlap between study pairs. Right axis: number of shared
gene symbols. Left axis: percentage of overlap calculated as (the number of shared gene symbols)/(the average number of gene symbols reported).
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Comparative analysis of fatty-acylation proteomic studies
A comparative analysis of our proteomics dataset with other recently described large-scale
studies of fatty-acylated proteins122,188-190 yields a significant degree of overlap with reported
fatty-acylated proteins as well as new candidate fatty-acylated proteins (Figure 14, Figure 15).
The proteomic analysis of alk-16 (17-octadecynoic acid 17-ODYA) labeled Jurkat T cells by
Martin and Cravatt using CuAAC ligation with biotin-azide, streptavidin enrichment and onbead digestion followed by multidimensional protein identification technology (MudPIT)-based
protein identification yielded ~125 high confidence fatty-acylated protein hits and another ~200
proteins with medium confidence122. Of the total list of fatty-acylated proteins identified by
Martin and Cravatt, 52 IPI numbers (or 82 considering possible alternate identifications) and 94
gene symbols were shared with our dataset, representing a 17% – 26% overlap (Figure 14A).
Even the lowest possible interpretation, this overlap is statistically significant for any reasonable
assumption of active genes. As determined by hypergeometric distribution,i the chance of 52
proteins being randomly choosen for these survey sizes from the full 74,016 enteries of the IPI
database is 1.08 E -67. At a reasonable number of expressible human genes, 24,500, the liklihood
has grown to 1.74

E

-43 and, assuming the 5381 proteins of Jurkat T cells identified by

proteomics210 represent the full repitoir of expressed proteins, the chance increases to a still
unlikely 1.60

E

-13. The number of expressed proteins must fall below 2294 for the chances of

i

The hypergeometric distribution calculates the chances of a given number of marked samples being taken from a
finite population of marked and unmarked entities without replacement. In the classical example, if x marbles are
taken from an urn with y white and z black marbles, it calculates the liklihood of choosing n black marbles. In this
case, the urn would contain e.g. 74,016 marbles of which 361 (the number of proteins identified in this work) would
be black. If 260 are chosen at random (the number of proteins identified in the Cravatt study), the chance of those
260 containing 52 black marbles is 1.08 E -67.
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random overlap to exceed 0.01, indicating that the overlap in protein identification is not
random.

In addition to the variability intrinsic to MS identification studies, two key features likely
account for differences among our Jurkat T cell datasets. Our studies were performed with total
cell lysates that included nuclear and cytosolic proteins, compared to enriched membrane
fractions from the Martin and Cravatt studies122. Moreover, the clickable and cleavable reagents
(alk-azo-biotin and az-azo-biotin) enabled the use of gel-based proteomics strategies, whereas
Martin and Cravatt utilized on-bead protease digestion and MudPIT-based protein identification
methods122. Our analysis also employed multiple fatty acid reporters, especially myristic acid
analogs, and recovered N-myristoylated proteins (e.g. PPM1G, MARCKS, ARF4 and ARF5) not
present in the Martin and Cravatt dataset (Figure 11), although alk-16 (17-ODYA) was also
reported to target some N-myristoylated proteins122. While many known and new candidate
fatty-acylated proteins from total cell lysates were identified in our high and medium confidence
datasets (Figure 11), selective recovery and enrichment of some known S-palmitoylated proteins
such as LAT not reaching those confidence levels could be clearly observed by Western blot
analysis of sodium dithionite elutions (Figure 12). Time of incubation with fatty acid analogs,
differential recovery of peptides by gel-based versus MudPIT proteomic strategies and subtle
differences in MS analysis can all play a role for the differences in fatty-acylated protein
profiling between this study and that of Martin and Cravatt.

ABE yields complementary datasets in comparison to CuAAC-based systems, as metabolic
incorporation of analogs is not required. The ABE analysis of membrane fractions from rat
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neural sources by the Davis laboratory yielded ~113 high confidence and ~318 medium
confidence S-acylated proteins211, 49 of these protein hits were also identified in our proteomic
dataset when compared by gene symbol (Appendix Tables 1, 2 and 3). ABE can also be
performed with isotopically-encoded thiol-alkylating reagents (iCAT) for comparative analysis
of S-acylated peptides, which identified ~46 S-palmitoylated proteins as well as their potential
sites of modification from HeLa cells189. Our study shares 29 gene symbols with this data and if
peptides are searched against our dataset, 61 IPI numbers are common (Appendix Tables 1, 2
and 3). These degrees of overlap are statistically significant (Table 5). ABE enrichment of Sacylated peptides from lipid-raft and non-lipid raft associated proteins from a human prostate
cancer cell line has also yielded ~67 known and ~331 candidate S-acylated proteins as well as
many potential sites of Cys modification190; of these, 69 were also identified by our study by
gene symbol or 68 by IPI number (Appendix Tables 1, 2 and 3). While the ABE and fatty acid
reporter proteomic studies were performed in different cell types and protein samples, the
proteomic studies using fatty acid chemical reporters in combination with CuAAC suggests that
bioorthogonal ligation methods can have higher signal-to-noise (Figure 12)122. For example, ~1/4
of proteins recovered from alk-FA labeling were also found in negative controls, whereas ~2/3 of
proteins recovered from ABE experiments were recovered from samples not treated with
hydroxylamine. With respect to the chemical linkage of fatty acid protein modification, fatty
chemical reporters enable the analysis of N-myristoylated proteins and other potential sites of
amino acid modification122 (Appendix Tables 1 and 2), whereas ABE selectively targets Sacylated proteins186,188-190 and has enabled identification of site modifications189,190. Although the
total number of proteins identified by ABE studies from three different protein sources was
higher, the overlap with this study was not substantially greater (107 gene symbols versus 94
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gene symbols;, see Figure 14 and Figure 15). Overall, both methods provide important insight
into the diversity and biochemical properties of fatty-acylated proteins.

Within all five studies, ~70% – 80% of proteins were observed in only one study (Figure 15 and
Appendix Table 3), ~15% – 20% were observed in two studies, ~5% – 7% were observed in
three and only 2% were observed in four studies. With the exception of some comparisons to
Zacharias data, the overlaps of all studies were statistically significant for reasonable
assumptions of the number of expressed proteins (Table 5). No proteins were observed in all
studies, reflective of the different methods of analysis, sample preparation and protein sources.
Of the high confidence lists only, C11orf59, Canx, FAM108B1, Gna13, Gnai2, Gnai3, Gnaq,
Gnas, KIAA0152, Snap23, Tfrc and Txndc1 were shared among four studies; expanding this to
include medium confidence hits, Cd81, Dnajc5, GNAO1, Igf2r, Rab1b, Rap2b, RPL12, Rpl5,
RPS3A, Scamp3, SLC25A5 are also observed. The greatest overlap between studies both in
number of shared gene symbols and percentage overlap was observed between the Cravatt and
Freeman studies (35%, 127 symbols), followed by Cravatt and this study (28%, 94 symbols) and
Davis and Freeman (27%, 100 symbols). The high degree of overlap between this study and
Cravatt’s is likely due the same cell type (Jurkat T cells) and use of fatty acid chemical reporters.
The Cravatt, Davis and Freeman datasets all analyzed membrane fractions of mammalian cells,
which likely favored identification of similar protein compositions.
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Table 5 Statistical significance of overlap between studies for Figure 15 using a hypergeometric
distribution with various assumptions of the number of active genes (expressed proteins). 5381
proteins were identified by proteomics in the global survey of Jurkat T cells210. All pairs but the
last are statistically significant even assuming 5381 (an underestimate) represents all proteins expressed in cells.
Gene

Pair
Cravatt,
Freeman
Cravatt,
Hang
Davis,
Freeman
Cravatt,
Davis
Freeman,
Hang
Davis,
Hang
Hang,
Zacharias
Cravatt,
Zacharias
Freeman,
Zacharias
Davis,
Zacharias

%
symbol
overlap overlap

p-value for assumed expression of
24,000 genes

12,000 genes

6,000 genes

5381 genes

3000 genes

35%

127

1.61E-142

3.31E-105

6.45E-69

2.23E-63

4.91E-35

28%

94

5.48E-96

9.39E-69

1.10E-42

8.93E-39

2.58E-19

27%

100

3.57E-97

2.32E-68

5.63E-41

6.71E-37

6.23E-17

23%

77

1.19E-70

1.00E-48

3.60E-28

3.71E-25

8.94E-11

19%

69

2.74E-54

3.42E-35

6.09E-18

1.60E-15

5.37E-05

14%

49

3.93E-34

5.13E-21

1.09E-09

3.43E-08

0.0175887

15%

29

1.01E-41

4.27E-33

1.40E-24

2.94E-23

2.66E-16

6%

11

4.54E-11

5.59E-08

4.03E-05

0.0001044

0.0091529

5%

12

1.38E-11

3.14E-08

3.81E-05

0.0001055

0.0117337

2%

3

0.026684

0.110640

0.229857

0.2321302

0.1071548

Functional analysis of fatty-acylated proteins targeted by chemical reporters
The large-scale analysis of proteins labeled with az/alk-FA chemical reporters of different chain
lengths provides the opportunity to evaluate the specificity and diversity of protein fattyacylation in mammalian cells. To determine the specificity of protein labeling with az/alk-FA reporters, the protein hits identified from our proteomics experiments were sorted into groups
based on the frequency of their recovery with different chain length of az/alk-FA reporters using
normalized peptide spectral counts. A survey of the protein hits revealed many proteins were la77

beled with multiple fatty acid chemical reporters (group VII) (Figure 11). In contrast, some proteins were labeled in a chain length-dependent fashion (group I and III) (Figure 11). For example, 44 proteins were only labeled by myristic analogs (az-12, alk-12) (group I) and 56 proteins
were uniquely labeled by stearic acid analogs (az-15, alk-16) (group III). Many proteins labeled
by alk-14 were targeted by shorter and longer fatty acid reporters (Figure 11), consistent with our
previous observations that this fatty acid analog labels both N-myristoylated and S-palmitoylated
proteins191. The fatty acid chain length labeling preferences were also evident by Western blot
analysis of selectively recovered proteins (Figure 12A and B). N-myristoylated proteins such as
ARFs were preferentially labeled by alk-12, whereas S-palmitoylated Ras was most efficiently
recovered with alk-16 (Figure 12A). Alternatively, N-myristoylated and S-palmitoylated proteins
such as Lck were recovered with multiple fatty acid reporters (Figure 12A). Other known Spalmitoylated proteins such as the transferrin receptor did not reveal a significant preference for
length of fatty acid reporters (Figure 12B). Differences in relative signal intensity of isoforms of
the same protein between input and elution, such as with the transferrin receptor, likely represent
preferential fatty-acylation of particular isoforms.

Bioinformatic prediction of fatty-acylation of recovered proteins
Analyzing our proteomic dataset with the N-myristoylation prediction program Myrbase183
showed that high and medium confidence predictions were limited exclusively to proteins of
groups I, II and III labeled by short-chain analogs (az/alk-12/alk-14) (Figure 11). At 0.49 ± 0.47,
the average confidence of predicted myristoylation for these groups is statistically different from
the average confidence for groups IV-VII (average = 0.03 ± 0.10; p = 1.16E-05, two-tailed heteroscedastic T-test). (Note that these averages represent a combination of confidence and frequen78

cy of prediction, as the absence of predicted myristoylation is included and given a confidence of
0. Thus, at ~0.5, all “average” proteins within groups I-III are predicted to be fully myristoylated
with half maximum confidence, or alternatively, half are predicted to be myristoylated with maximum confidence and half are predicted to bear no myristoylation.) In contrast, the CSS-Palm
prediction program based on previously reported S-palmitoylated proteins22 predicted fattyacylation of proteins throughout the dataset (Figure 11). Predicted palmitoylation showed little
correlation with chain length of fatty acid analog and less statistical difference (confidence of
predicted palmitoylation for groups I-III, 0.71 ± 0.42; confidence in groups IV-VII, 0.51 ± 0.51;
p = 0.03, two-tailed heteroscedastic T-test). The less significant difference between groups I-III
and IV-VII is likely not reflective of biological correlation but rather the bias of prediction from
known motifs: only 45% of proteins in groups IV-VII have been reported by any study, whereas
63% have been reported for groups I-III. Assuming that the average predicted confidence of
palmitoylation based on known motifs scales linearly with the number of previously identified
palmitoylated proteins, if 63% of proteins had been previously identified in groups IV-VII as
they were for groups I-III, the average confidence of palmitoylation would increase to 0.70 and
the statistical significance by the same test would increase to p = 0.90. Thus, palmitoylation prediction was distributed more or less uniformly and did not correlate to any particular analog
chain length. These results are consistent with the reported specificity of protein fatty-acylation,
which found that NMTs preferentially utilize myristoyl-CoA through a relatively defined enzyme active site for N-myristoylation of proteins212, whereas S-acylated proteins typically contain a heterogeneous composition of fatty acids of different chain lengths and unsaturation18,19,213,214.
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Annotation of subcellular location of identified proteins
We evaluated the subcellular localization associated with proteins recovered from fatty acid
chemical reporter labeling. It should be noted that protein samples from our studies represent an
unbiased total cell lysates from lysis and solubilization using strong detergent (4% SDS) after
nuclease treatment (benzonase), which eliminated the presence of any insoluble pellet. Our lysate
thus includes nuclear, cytoplasmic, organelle and membrane proteins. Predicting protein localization for our dataset with the WoLF PSORT subcellular prediction algorithm215 revealed that
the majority of recovered fatty-acylated proteins are expected to be cytosolic (61%), with the
remainder distributed to nuclei (17%), mitochondria (12%) and membranes (10%) (Figure 14D,
Appendix Table 4A). Similar results were obtained from a corrected Bonferroni test for enrichment of GO cellular component annotations of recovered proteins (p-value < 0.01). Cytosolic
and cytoplasmic annotations were the most enriched (18% and 32% respectively) followed by
mitochondrial (11%), nuclear (6%) and ribosomal annotations (2% – 6%) (Figure 16, Table 6).
Annotated and predicted localizations contrast in particular for membrane and cytosol with recent experimental data of Jurkat T cells generated by biochemical subcellular fractionation and
proteomic analysis210. Based on that data, az/alk-FA-labeled proteins partition primarily in membranes (50%), followed by cytosol (37%), nucleus (10%) and mitochondria (3%) (Figure 14E).
The difference between the predicted and experimental subcellular localization suggested that
many proteins predicted or annotated to be cytosolic may be membrane associated through fattyacylation. Interestingly, proteins recovered from total cell lysate were also significantly enriched
in nuclear proteins (APEX1, HNRNPF, HNRNPH1, HNRNPL, DDB1, MCM2, MCM3, MCM6,
NCL, PARP1, PCNA, PHB, PPP1CB, RANP1, RPS2, SUPT16H, UBC, XPO1, XRCC5,
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XRCC6), suggesting that protein fatty-acylation could contribute to dynamic membrane targeting within the nucleus as well.

Figure 16 Enriched GO annotations of cellular component, sorted by corrected p-value. 204 proteins from high and medium confidences bore cellular component annotations and were tested
with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered proteins were most enriched in cytosolic and cytoplasmic, ribosomal, nuclear, mitochondrial and ribonuclear proteins.

Table 6 Enriched GO annotations of cellular component. Tabular data to Figure 16. Sorted by
corrected Bonferroni p-value.
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Function, biological processes and pathways of identified proteins
The biological processes of proteins labeled with fatty acid chemical reporters were first examined manually (Figure 14F, Appendix Table 5), revealing that fatty-acylated proteins take part in
wide range of cellular processes from signal transduction to protein synthesis and degradation.
Statistical analysis of GO annotations using the Bonferroni correction (p-value < 0.01) revealed
multiple enriched annotations within identified fatty-acylated proteins. Within molecular function, identifications were enriched in proteins that bind nucleotides, unfolded proteins and other
proteins; proteins with GTPase activity and those binding GTP or ATP; proteins of the ribosome;
and proteins which bind RNA (Figure 17 and Table 7). These molecular functions correlate well
to enriched GO biological process annotations: most enriched were proteins involved with transitional elongation (ribosomal proteins); protein folding, refolding and polymerization (processes
requiring nucleotide, ATP or GTP binding); cellular component movement (ATP and GTP binding); several ubiquitin-dependent proteasome processes; and telomere maintenance (Figure 18,
Table 8; appendix I). Finally, networks of functional association and protein-protein interactions
within identified proteins were analyzed and visualized using STRING216, a database and data
mining tool which distills a wide variety of information to confidences of protein interactions
that are then clustered (Figure 19). A high confidence level of interaction (0.876), this analysis
strikingly revealed tight associations within the large protein complexes of the ribosome (circled
in blue), heterogeneous nuclear ribonucleoprotein complexes (hnRNPs, yellow), and the proteasome (green). In addition to these highly pronounced associations, seven other major networks were also apparent involving: interrelated cytoskeleton components including 1) the tubulins in particular and their regulatory molecules (highlighted in red); 2) actins and their regulatory molecules (periwinkle), and 3) myosins (rose); 4) the 14-3-3 adaptor proteins which modulate
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the activity of binding partners in a wide variety of signaling pathways (purple); 5) a large number of guanine nucleotide-binding proteins (G proteins, which serve to modulate or transduce
transmembrane signal systems), connected with several membrane-bound kinases and members
of the Ras family (brown); 6) an association of proteins involved in nuclear processes including
DNA damage repair and maintenance, cell cycle progression, nucleoside metabolism and nuclear
chaperonins (light green); and 7) enzymes of sugar metabolism including the interrelated glycolysis/gluconeogenesis, fructose/mannose, pentose phosphate and pyruvate metabolic pathways
(pink). Additional networks included nuclear transport (teal), mitochondrial electron transport
(grey) and ATP synthesis (orange), and multiple DNA replication licensing factors of the highly
conserved mini-chromosome maintenance proteins (MCM) involved in the initiation of eukaryotic genome replication (light blue). Notably, HSP90α sat at the center of the interconnected
networks (red asterisks), closely flanked by HSP90β and other heat shock proteins.
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Figure 17 Enriched GO annotations of molecular function, sorted by corrected p-value. 197 proteins from high and medium confidences bore molecular function annotations and were tested
with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered proteins were most enriched in proteins that bind nucleotides, unfolded proteins and other proteins, proteins with
GTPase activity and those binding GTP or ATP, proteins of the ribosome and those which bind
RNA.

Table 7 Enriched GO annotations of molecular function. Tabular data to Figure 17. Sorted by
corrected Bonferroni p-value.
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Figure 18 Enriched GO annotations of biological process, sorted by corrected p-value. 194 proteins from high and medium confidences bore cellular component annotations and were tested
with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered proteins were most enriched in proteins involved with transitional elongation; protein folding, refolding and polymerization; cellular component movement; several ubiquitin-dependent proteasome processes; and
telomere maintenance. See also Table 8 for complete descriptions.

Table 8 Enriched GO annotations of biological process. Tabular data to Figure 18. Sorted by
corrected Bonferroni p-value.

85

Figure 19 Functional and protein-protein interaction networks within identified fatty-acylated proteins of both high and medium confidences. A STRING216 analysis of interactions at a high confidence level (≥0.876) revealed highly interconnected associations of
three large protein complexes including the ribosome (circled in blue); heterogeneous nuclear ribonucleoprotein complexes (hnRNPs,
yellow); and the proteasome (green). Seven other major networks were also apparent involving: interrelated cytoskeleton components
including 1) the tubulins in particular as well as their regulatory molecules (highlighted in red); 2) actins and their regulatory molecules (periwinkle), and 3) myosins (rose); 4) the 14-3-3 adaptor proteins which modulate the activity of binding partners in a wide variety of signaling pathways (purple); 5) a large number of guanine nucleotide-binding proteins (G proteins, which serve to modulate or
transduce transmembrane signal systems), connected with several membrane-bound kinases and members of the Ras family (brown);
6) an association of proteins involved in nuclear processes including DNA damage repair and maintenance, cell cycle progression, nucleoside metabolism and nuclear chaperonins (light green); and 7) enzymes of sugar metabolism including the interrelated glycolysis/gluconeogenesis, fructose/mannose, pentose phosphate and pyruvate metabolic pathways (pink). Additional networks included nuclear transport (teal), mitochondrial electron transport (grey) and ATP synthesis (orange), and multiple DNA replication licensing factors of the highly conserved mini-chromosome maintenance proteins (MCM) involved in the initiation of eukaryotic genome replication (light blue). Note the presence of HSP90α at the center of the interconnected networks (red asterisks), closely flanked by HSP90β
and other heat shock proteins.
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Correlation of fatty-acylation amd protein cysteine content
Examination of the relationship between MS spectral counts and cysteine content of proteins
identified in either positive fractions or negative fractions for both high and medium confidence
levels revealed no correlation (R2 < 0.1) (Figure 20). Proteins with no or very low cysteine content were found to have relatively large numbers of spectral counts in both positive and negative
enrichments. Likewise, proteins with higher cysteine contents exhibited both high and low signal
in both enrichment sets.

Figure 20 Total observed counts for proteins identified in high and medium confidences as a
function of cysteine content. Top chart: proteins identified enriched in positive fractions, log
scale. Bottom chart: proteins identified enriched in negative fractions, log scale, inverted. No
significant correlation exists between cysteine content and total observed counts for either group.
The insignificant correlation which does exist is negative for counts enriched in positive fractions, reflecting decreased counts with increased cysteine content, and likewise positive for
counts enriched in negative fractions, reflecting decreased counts with increased cysteine content.
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Discussion
Unraveling the diversity of fatty-acylated proteins and the underlying regulatory mechanisms of
protein fatty-acylation in eukaryotes is a challenging task. In this work, the large-scale identification of fatty-acylated proteins from mammalian cells has been performed using azide/alkynefunctionalized fatty acids from an unbiased, fully solubilized protein preparation. The enrichment and proteomic analysis of proteins targeted by fatty acid reporters has revealed 57 known
fatty-acylated proteins as well as 109 new candidate proteins (by gene symbol) with high confidence that may be regulated by protein fatty-acylation; extending the list to include high and medium confidence, this study identified 191 new candidate proteins and shared 154 identifications
(Figure 15B and C). The comparison of azide- and alkynyl-fatty acid chemical reporters of various chain lengths highlights the utility of both classes of lipid analogs for detecting fatty-acylated
proteins as well as the selectivity of protein fatty-acylation in cells.

Mechanisms of fatty-acylation
The mechanism of fatty-acylation for proteins identified in our survey including histone H3
could be due to chemical S-acylation (background reactivity, Figure 21A), substrate-mediated Sacylation (auto- or self-acylation, Figure 21B), enzyme-catalyzed S-acylation (i.e. DHHC-PATs,
Figure 21C), or some combination of these factors (Figure 21). At sufficient concentrations, coenzyme A activated fatty acids are capable of spontaneous chemical S-acylation on cysteine residues of proteins (GAPDH217; SNAP-25218; tubulin219,220; rhodopsin221; G protein α subunits222;
myelin proteolipid protein (MPP)223; actin, lactate dehydrogenase, fetuin224; Bet3225) and also
short peptides containing the natural site of protein palmitoylation224,226. Many of the proteins
demonstrated to undergo chemical acylation are also substrates for PATs (SNAP-25227; tubulin
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and G protein subunits220; rhodopsin221) and many also undergo catalytic self-palmitoylation
(GAPDH228, SNAP-25218, MPP223, Bet3225). Likewise, DHHC-PATs load themselves prior to
palmitoyl transfer through an auto-acylation event229. Auto-S-palmitoylation can occur in a regulated fashion such as in response to fatty acid levels (GAPDH217) or protein-protein interactions
(SNAP-25 palmitoylation is 100-fold greater when bound in the SNARE complex218; likewise,
the presence of Gβγ enhances Gα palmitoylation222). This combination of mechanisms has complicated analysis of the regulation of S-palmitoylation.

S-acylation depends on two factors: the concentration of activated CoA ester and the relative reactivity of the cysteine. Reactivity depends on chemical accessibility and the concentration of
thiolate anion capable of a nucleophilic attack, which is enhanced by physical proximity to basic
residues225,230-232 (Figure 21B and C). For DHHC-PATs, mutation of the cysteine-proximal basic
residues (aspartic acid and histidine) sharply reduces or abrogates transferase activity229,233. Local concentration of fatty acid-CoA, and thus acylation, is favored by hydrophobic residues near
a site of modification230,234; similarly, DHHC-PATs can place a bound fatty acid at a specific residue. Within mammalian cells, the global concentration of activated free fatty acids is kept to
low nanomolar concentrations by the presence of acyl-CoA binding protein (ACBP)235,236. Because most studies of chemical acylation have not included ACBP and have extended the concentration of activated fatty acids even into the millimolar range, their results must be interpreted
cautiously. Upon the inclusion of ACBP, chemical acylation of peptides and proteins can be
eliminated; this buffering does not affect DHHC-PAT activity224,235,237 and the effect on selfpalmitoylating proteins has generally not been studied.
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Figure 21 Mechanisms of protein S-acylation (palmitoylation). Mechanisms are not exclusive
and may occur simultaneously. A) Chemical modification between coenzyme A activated fatty
acids and cysteine-containing proteins (blue) can occur at sufficiently high concentration of fatty
acid-CoA. In most of the cell, acyl-CoA binding protein (ACBP, green) normally buffers activated fatty acids to the low nanomolar range, quenching this mechanism. However, in mitochondria, chemical modification may play a greater role. B) Catalytic substrate-mediated (or auto- or
self-acylation) occurs for a number of proteins, including DHHC-PATs, where the reaction prepares the PAT for palmitoyl transfer to other proteins. S-acylation is assisted by cysteine proximity to basic residues, which favor formation of a thiolate anion, and proximity to hydrophobic
residues, which favor increase local concentration of fatty acid-CoA. DHHC-PAT activity is uninfluenced by ACBP; the effect of ACBP on other self-acylating proteins has not been studied.
Protein-protein interactions can greatly influence the rate of auto S-acylation. C) Enzymatic
DHHC-PAT-mediated palmitoylation likely occurs via a similar mechanism and many proteins
that show self-modification are PAT substrates. A catalytic base is shown and might belong to
either the DHHC-PAT (purple) or substrate protein. PAT specificity results from distinct PATprotein interactions. The exact mechanism of DHHC-PAT-mediated palmitoylation remains a
topic of study.
91

Other possible mechanisms of fatty-acylation
In addition to the cellular mechanisms of Figure 21, post-lysis acylation could result from disrupting ACBP binding, releasing activated fatty acids, and the simultaneously exposure of buried
free cysteines such as C110 of H3 variants. The extent of this reaction will depend on the concentration of CoA activated fatty acid; in the case of click chemistry analysis, the relative concentrations of clickable and native fatty acids; the concentrations of protein; the relative concentration of other thiols such as glutathione; and finally the time and temperature before small molecules are removed from lysate proteins, e.g. by precipitation. No studies of protein fattyacylation to date have addressed this possible mechanism and specific strategies to elucidate its
potential contribution are described below in Future Directions.

Fatty-acylation does not correlate to protein cysteine content
While post-lysis modification with fatty acids cannot be excluded without additional experimentation, the prevalence of such a mechanism would favor higher recovery of proteins with high
cysteine content. No significant correlation was found between cysteine content and MS counts
(R2 < 0.1) (Figure 20). The poor correlation that does exists for positive counts in excess of negative is negative, reflecting a decreased overall signal with increased cysteine content, and the
small correlation between negative counts in excess of positive is positive, reflecting decreased
signal in negative samples with increasing cysteine content. Cysteine content alone is thus unpredictive of enriched peptide counts, suggesting that post-lysis does not significantly contribute
to recovered signal. However, this represents and overall trend and in particular for proteins such
as H3, in which a free sulfhydryl is known to be maintained and which is present in large quanti-
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ty, exceptions may be present. Further experimentation will shed light on this possibility (see Future Directions).

Possibility of “in vivo chemical fatty-acylation”
In addition to the mechanisms of Figure 21 and ex vivo post-lysis chemical acylation, the possibility for a sort of “in vivo chemical palmitoylation” exists for enzymes with highly reactive
functional groups, in particular (but not exclusively) cysteine sulfhydryls. Such reactive functional groups are abundant in enzymes with oxidoreductase activity, such as the peroxiredoxins,
and are also present in enzymes subject to redox control like the serine/threonine protein phosphatase-1 subfamily238. The active nature of these sulfhydryls presents the possibility of an almost immediate reaction with any nearby molecules of activated CoA esters; if depalmitoylation
is kinetically slower, a palmitoylated state would be favored. Such “background” chemical acylation might be purposeful, as for the regulation of GAPDH activity, or alternatively might represent true background chemical reaction within the cell cleared either by intrinsic activity or an
extrinsic enzyme. Notably, five of six peroxiredoxins were identified in this dataset, multiple
members of the protein phosphatase-1 family and over 20 proteins bearing annotations of redox
activity (see Table 9). One of the few proteins found to be common to four studies, thioredoxin
domain-containing protein 1, was also identified, suggesting this mechanism could be widespread. Most of these proteins displayed a preference for fatty acid chain length, either long or
short, and while this behavior would be unexpected in the denatured state, such preferences can
be easily interpreted as the result of unique protein properties such steric accessibility or size and
layout of hydrophobic and electrostatic interactions. Many of these proteins or their relatives
were also detected in ABE experiments performed on rat brain tissue (Appendix Table 3), sug93

gesting that detection of such reactive proteins is not unique to cell culture or click chemistry.
However, as with post-lysis modification, analysis of the possibility of in vivo chemical modification of reactive proteins will require further experimentation. The question would best be addressed by monitoring possible a reaction in vitro between purified proteins, such as those of Table 9, and a traceable fatty acid analog CoA-ester (radioactive or clickable) at low concentration
preferably in the presence and absence of ACBP. Increased modification with time would present strong evidence that this mechanism occurs in vivo. Modification to unity would reflect extrinsic de-acylation while an equilibrium state of partial fatty-acylation indicates the proteins
have an intrinsic de-acylation activity.
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Table 9 Proteins identified in this work annotated to have redox function.
Protein name
APEX nuclease (multifunctional DNA repair enzyme)
C-1-tetrahydrofolate synthase, cytoplasmic
Cytochrome c oxidase subunit II
D-3-phosphoglycerate dehydrogenase
Glutamate dehydrogenase (NAD(P)+)
Hydroxyacyl-Coenzyme A dehydrogenase, type II
Isocitrate dehydrogenase [NADP], mitochondrial
Lactate dehydrogenase B
Malate dehydrogenase, mitochondrial
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial
Peroxiredoxin-1
Peroxiredoxin-2
Peroxiredoxin-3
Peroxiredoxin-4
Peroxiredoxin-5, mitochondrial
Protein disulfide-isomerase
Protein disulfide-isomerase A3
Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
Synaptic vesicle membrane protein VAT-1 homolog
Thioredoxin domain-containing protein 1
Trifunctional protein alpha-subunit

Symbol
APEX1
MTHFD1
COX2
PHGDH
GLUD1
HADH2
IDH2
LDHB
MDH2
NDUFS1
PRDX1
PRDX2
PRDX3
PRDX4
PRDX5
PP4HB
PDIA3
SDHA
VAT1
TXNDC1
HADHA

Chain length preference in fatty-acylation
Preference for particular fatty acid chain lengths was seen dramatically for proteins such as
ARFs, RAS or coronin 1A (Figure 12), but not for others such as VCP or Lck. Several factors
likely combine to result in such biases. Enzymatically, both NMTs and DHHC PATs have been
shown to have relatively broad substrate recognition centered on myristic acid (14 carbons176)
and somewhere around palmitic and stearic acids (16 – 18 carbons216), respectively. Especially in
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the case of dual myristoylation and palmitoylation, such as for Lck, no particular chain length
preference is expected and none was observed. Likewise, for proteins bearing a sole myristoylation, as for the ARFs, a strong preference for myristic acid analogs is expected and was observed (Figure 12). In the case of palmitoylation by DHHC-PATs, while substrate chain length
preference has been observed in competition experiments216, the unknown enzyme structure and
modification mechanism leaves multiple questions for the many mammalian transferases. First,
the fatty acid substrate specificity of distinct PATs remains unknown and may be PAT-specific,
perhaps controlled at their loading step. Second, the protein substrate specificity of loaded PATs
remains unresolved. Thus, the chain length preference shown by Ras could be explained by modification with one or more PAT preferring a longer chain length, while likewise, the lack of specificity seen for VCP could reflect modification with PATs showing reduced specificity, or even
modification by PATs with enhanced recognition of shorter chain lengths. Third, in addition to
the affinities between PATs and their protein substrates, the protein to be acylated could interact
with the specific fatty acid loaded on the transferase to foster or discourage binding and thus Sacylation. For example, by sterically protruding into a region filled by longer, but not shorter,
fatty acids, protein substrates could be preferentially modified by binding PATs bearing shorter
length fatty acids. Analogous interactions might exist for preference of longer chain lengths.
PAT protein substrates may thus themselves provide an additional level of chain length preference in addition to the preference of the modifying PAT(s). For auto-acylation including PAT
loading, hydrophobic, electrostatic, hydrogen bonding and steric interactions will govern substrate binding and result in energetic preference for some particular chain length; in the case of
desaturation or similar chain length, preference may be very close, as previously described216.
Finally, fatty-acylation of all types will be subject to simple stoichiometry: given a large enough
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excess of a non-ideal chain length, incorporation of that fatty acid will be favored even in the
presence of better substrates.

Metabolic modification of fatty-acid analogs
Due to the terminal position of their functionalization, both alkyne and azido fatty acid analogs
are likely subject to catabolic and anabolic processes. Over time, these processes may alter the in
vivo composition of analog chain length. This possibility is supported by the detection of many
known myristoylated proteins after overnight incubation with alk-16122. Likewise, ARF modification with palmitic or stearic acid analogs was detected in this work (Figure 12), although with
substantially reduced signal. Both enzyme substrate tolerances and metabolic processes could
explain these observations. However, the strong influence of analog chain length on recovered
signal for proteins like the ARFs indicates that metabolic exchange did not equalize the chain
lengths of added analogs within the experimental timescale. The exact nature of fatty acid metabolism may be complex and will depend on time and metabolic state. For example, catabolism
will be favored under conditions of limited energy or high metabolic demand. Similarly, given
sufficient energy, added analog chain length will likely be subject redistribution towards the fatty
acid chain length equilibrium of the cell. Other sources of fatty acids, such as from cell culture
sera, will also influence this redistribution. Thus, outwardly similar experimental conditions may
yield potentially unexpected differences in metabolism. However, within study of protein fattyacylation, the effect of metabolism may be minor: given sufficient sensitivity, the reduced yet
present incorporation of non-optimal chain lengths for a given fatty acid transferase will always
be observed and the substrate tolerance of myristoylation and palmitoylation machinery216176 indicates that the biological effect of two more or two less carbons is not substantial. This may be
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especially true for fatty-acylation: in contrast to incorporation of amino acids or nucleotides, fatty acids from 12-20 carbons have relatively similar properties within an aqueous environment. In
addition, because lipidated proteins often bear multiple lipid modifications, the effect of small
differences in chain length will often be diluted. The chain length preferences of NMTs and
PATs may thus not reflect overall requirements of hydrophobicity but rather the evolution of systems of control (constitutive and dynamic). Teasing out the contribution of metabolism on added
fatty acid analogs will be most easily accomplished by MS analysis of the modified peptides to
establish the fatty acid composition. Such detail will also provide insight into the proportion of
modification. Until such experimentation, at least within the conditions of this work, the observation of substantial chain length preference of particular proteins for both short and long chains
indicates that metabolic exchange did not equalize the concentration of myristic to stearic acid
analogs and all proteins predicted to be myristoylated with high or medium confidence fell within the groups modified by myristic acid (Figure 11).

General implications for fatty-acylation and its study
Given the unbiased approach of this survey and the discovery of fatty-acylated proteins throughout diverse cellular compartments, the best conclusion might well be “What does it mean?” and
the next perhaps “What is the next study?” These questions can be neither quickly dismissed nor
quickly addressed, and their accurate answer lies in much future experimental work. However,
contrasting Figure 2 and Figure 19, we begin to gain some insight into the full implications of
this work.
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Figure 2 represents the prevailing view of fatty-acylation: the modification, which can be dynamic in the case of palmitoylation, results in membrane association of proteins from a wide variety
of membrane-related processes and regulates protein function by controlling subcellular location.
This view is not incorrect and, in Figure 19, is reflected in the tight networks of G-proteins and
14-3-3 adapters. Both protein families are known to be heavily involved in signaling and signal
modulation at the membrane. Despite these two similarities, Figure 2 and Figure 19 are strikingly
different. In particular, Figure 2 bears no mention of the cytoskeleton, which must interface by
some mechanism with membranes throughout the cell; it illustrates the nucleus but reports no
role for fatty-acylation in any nuclear process, and likewise it shows no role of myristoylation or
palmitoylation in metabolismii or protein complexes, in particular the ribosome and proteasome,
nor within complexes of mitochondria. Statistical analysis of GO annotations shows that the proteins identified in this work support the networks of Figure 19. Enriched cellular component annotations include cytosolic, nuclear, mitochondrial, ribosomal and ribonuclear proteins (Figure
16 and Table 6; note that cytoskeletal proteins are annotated as cytosolic), in good agreement
with the networked clusters. Correspondingly, enriched biological process annotations include
translational elongation, protein polymerization, cellular movement (which includes cytoskeletal
proteins and their regulators) and telomere maintenance (Figure 18 and Table 8). Protein folding
and refolding processes were also statistically overrepresented, matching the central, chaperonsurrounded HSP90α hub of Figure 19 (marked with a red asterisks). Enriched molecular functions reflect these biological processes and include binding of nucleotides and RNA, proteins and
unfolded proteins, ATP or GTP, as well as GTP hydrolysis (Figure 17 and Table 7). Thus, this
ii

Notably, GAPDH has the largest number of connections within the metabolic network (10 spokes) and was found
to be regulated by autocatalytic palmitoylation, which was proposed to have a regulatory role in the context of sugar
metabolism217.
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work first suggests broader involvement of fatty-acylation in cellular processes and subcellular
localizations than is currently appreciated.

Behind the disparity in overviews of Figure 2 and Figure 19 lies the influence and importance of
sample preparation in the study of fatty-acylation: of the five current global studies of protein
acylation, only this work analyzed fully solubilized cells while the other four employed membrane preparations, continuing a historical trend. For decades, membrane fractionation and mild
detergent solubilization (RIPA, NP40, Brij, etc.) have been a common first step in the study of
fatty-acylated proteins239,240 despite the fact that both techniques leave behind large, undissolved
and typically unanalyzed pellets. Data from the global proteomics survey of Jurkat T cells210
yield a sense of the compositional difference between the lowly pellet and membrane fractionation. Within the 5381 proteins confidently identified, 25% were common to membrane and cytosolic fractions, 27% to membrane and nuclear fractions and only 14% were detected in all three
fractionations. Well correlating to these proportions, 17% – 26% of fatty-acylated proteins were
shared in common between this study and that of Cravatt122 which employed a closely similar
experimental approach with membrane fractionation of the same cell line as this study, and this
study identified a total of 101 more proteins. Thus, this work secondly indicates the examination
of proteins from membrane fractionation has left undetected large populations of proteins present
in subcellular locations other than membranes. Discoveries have consequently converged on a
membrane-centric view of the modification (Figure 2).
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Figure 22 Enriched GO annotations of cellular component for full Cravatt dataset122, sorted by
corrected p-value. 133 proteins identified bore cellular component annotations and were tested
with a Bonferroni and corrected Bonferroni test. Three components were enriched at p < 0.01.

Table 10 Enriched GO annotations of cellular component for full Cravatt dataset122. Tabular data
to Figure 22. Sorted by corrected Bonferroni p-value.

Supporting this conclusion, different sample preparations from the same cell line identified proteins from different cellular compartments and membrane fractionation yielded fewer statistically
significant enrichments of cellular component. Repeating the analysis of Figure 16 and Table 6
for the full Cravatt dataset (Figure 22 and Table 10), three enrichments of cellular component
were apparent versus nine for this work and the average statistically significance of enrichment
was 16-fold lower (average corrected p value = 1.28 E -4 for this work vs. 2.01 E -3 for the Cravatt dataset). Only enrichments of cytosolic annotations were common to this study and compo101

nents of the membraneous Golgi apparatus were statistically overrepresented. The contrast in
type and number of cellular component enrichment is first partially reflective of statistics. Within
the proteins of this study, a similar yet smaller number of proteins were annotated to be part of
the proteasome complex (5 vs. 7) and Golgi apparatus (15 vs. 19) but due to the lesser representation and the larger sample size of this dataset (361 vs. 260 proteins), these annotations did not
reach statistical confidence. Second and more significantly, the differences in enrichment reflect
the breadth and depth of sampling. Membrane preparation presents only the membraneassociated proteins of any given cellular component, hindering the identification of cellular components which contain protein members not bound to membranes. In the same way, the preparation favors enrichment of fully membraneous cellular components like the Golgi. For Jurkat T
cells, these factors combined to yield a three-fold lower number of cellular component enrichments overall yet also new enrichments reflective of membrane preparation enrichment. Thus
thirdly, this work suggests that analysis of the fraction(s) remaining after a membrane preparation could addess the bias of sample preparation while simultaneously maintaining enhanced detection of low-level membrane bound proteins.

A comparison of the 52 proteins shared in common between the two studies (or 82 considering
possible subhit interpretations; see Appendix Table 3) to the dataset as a whole verifies the bias
introduced by membrane fractionation. Compared to the full cohort (Figure 14F) in which 10%
of proteins are predicted to be membrane bound and 50% were experimentally observed in
membrane fractions, 14-18% of the shared 52-82 proteins are predicted to be membrane bound
and 51-56% were experimentally observed (Figure 23). The skew towards a higher membrane
composition is expected given the membrane preparation used in the comparison study. Cellular
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component annotations of the common 52 proteins (Figure 24, Table 11) share statistical enrichment of cytosolic, cytoplasmic and ribosomal annotations with the full dataset; these annotations are often associated with membranes as shown by Figure 14 and Figure 23. However, distinctly missing from enriched annotations are non-membrane cellular components such as the
nucleus and mitochondria. These differences are echoed by changed annotation enrichments of
molecular function and biological processes (Figure 25, Figure 26, Table 12, Table 13): while often membrane-bound translational and ribosomal annotations remain enriched, others like cellular movement (i.e. cytoskeleton) are lost. Correspondingly, molecular functions like GTP binding and GTPase activity are no longer enriched but those common among membrane proteins,
such as protein and nucleotide binding ubiquitous for G-protein subunits, remain. Due to the
small sample size, multiple statistically significant enrichments are present for processes with
small numbers of members. However, while the presence within 52 proteins of one member of a
two-member annotation set is statistically significant (Figure 24, Figure 25, Figure 26, Table 11,
Table 12, Table 13), meaning beyond the presence of fatty-acylation for that protein is tentative.
Thus, the proteins shared with the Cravatt study are expectedly enriched in membrane bound
proteins and often bear cytosolic and ribosomal annotations. Reflective of membrane selection,
the common proteins lack cellular components, molecular functions and biological processes associated with the nucleus, cytoskeleton or mitochondria.
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Figure 23 Predicted and observed subcellular location for proteins common to the data of this
work and that of Cravatt122.
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Figure 24 Enriched GO annotations of cellular component for the 52 proteins shared between
this and the Cravatt studies, sorted by corrected p-value. 32 proteins identified bore cellular
component annotations and were tested with a Bonferroni and corrected Bonferroni test. Six
components were enriched at p < 0.01 including those of the cytoplasm and ribosome. Contrasting the full dataset, component annotations of mitochondria and nuclei are not longer present. Given the small sample size, components with small numbers of annotations are statistically significant if only one member of the set is present (see also Table 11). Such enrichments may
or may not have biological meaning.

Table 11 Enriched GO annotations of cellular component for the 52 proteins shared between this
and the Cravatt studies. Tabular data to Figure 24. Sorted by corrected Bonferroni p-value.
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Figure 25 Enriched GO annotations of molecular function for the 52 proteins shared between
this and the Cravatt studies, sorted by corrected p-value. 29 proteins bore molecular function annotations and were tested with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered
proteins were most enriched in proteins that bind nucleotides and proteins, and those involved in
translation including the ribosome. See also Table 12 and note regarding enrichment of annotations with few members in Figure 24.

Table 12 Enriched GO annotations of molecular function for the 52 proteins shared between this
and the Cravatt studies. Tabular data to Figure 25. Sorted by corrected Bonferroni p-value.
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Figure 26 Enriched GO annotations of biological process for the 52 proteins shared between this
and the Cravatt studies, sorted by corrected p-value. 30 proteins bore biological process annotations and were tested with a Bonferroni and corrected Bonferroni test. At p < 0.01, translational
elongation remained. See also Table 13 and note regarding enrichment of annotations with few
members in Figure 24.

Table 13 Enriched GO annotations of biological process for the 52 proteins shared between this
and the Cravatt studies. Tabular data to Figure 26. Sorted by corrected Bonferroni p-value.
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In addition to sampeling proteins outside a membranous environment, the complete solubilization strategy employed here contributed in a second manner to the identification of previously
unidentified fatty-acylated proteins and protein networks. Observation of fatty-acylation on highly abundant, often sticky proteins such as those of the ribosome, cytoskeleton and metabolic enzymes has often been obscured by difficulty in distinguishing genuine bound signal from background binding to beads. This limitation results from wash conditions insufficient to effectively
remove plentiful proteins and can easily result in false negative assignments. Wash conditions
typically present an experimental challenge: a balance must be struck between loss of proteins of
interest and background binding. However, the combination of click chemistry with biotin capture presents one of the few experimental systems amenable to extreme stringency of wash. This
harshly solubilizing detergent conditions used in this work during labeling and capture (0.5% –
4% SDS) combined with highly stringent washes (2% SDS, 8 M urea, 2.5 M NaCl and more) enabled reliable identification of abundant ribosomal, cytoskeletal and metabolic proteins. Under
these conditions, weak but dectable background was still observable for abundant proteins like
actins and tubulins, heat shock proteins and some metabolic enzymes (enolase and phosphoglycerate kinase, see Figure 11) but similar background was not observed for ribosomal, mitochondrial or proteasomal proteins. Western blotting for multiple proteins confirmed the lack of
background binding and, in the case of HSP90, revealed MS detection of background binding to
be more sensitivity than ECL at that exposure (Figure 11, Figure 12, Figure 13). Thus forthly,
this work presents an experimental approach which enables distinction of true signal from high
abundance proteins and has reliably detected fatty-acylation on highly abundant, sticky proteins.

108

As with all research, discoveries within fatty-acylation have flowed from the solubilized proteins
of a sample. Major complexes and networks, in particular tightly-packed chromatin of the dense
nucleus, as well as the cytoskeleton and others, are not brought into solution with typical approaches. They have thus remained largely or fully unexamined. In addition, the use of membrane preparations, while they enrich membrane-associated low-level proteins, has directed our
view of fatty-acylation to a membrane-centric view. Multiple reviews summarize similarly to
“Whereas kinase and phosphatase activity generally acts by directly modulating protein-protein
interactions, palmitoylation is more likely to achieve its affects via regulation of proteinmembrane interactions”241 yet neglect to mention that other cell regions have been examined
minimally at best. Overarchingly, the implication of this wok is that fatty-acylation is present
throughout the cell, rather than one restricted to membrane-associated proteins, and plays a role
in diverse processes from metabolism and energy production to protein maintenance and folding
to the cell cycle.

If, then, fatty-acylation is so widespread, what is its role? We can best understand its broader implications first principles. Like hydrophobic sections of proteins, the addition of fatty acids can
certainly serve to generate membrane affinities, but they can also serve to create intra- or intermolecule affinities. Hydrophobic interactions underlie protein and protein-complex stability (including that of histone octamers) and lipidation, in particular dynamic palmitoylation, represents
an efficient mechanism to modulate hydrophobicity. This modulation can change interactions
within proteins, altering conformations and thus activities, as well as between proteins. In addition, lipid modifications alter chemical reactivity by capping a sulfhydryl, hydroxyl, amine or
other functional groups; this change may result in alterations in catalytic activity of enzymes.
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Thus, like phosphorylation, fatty-acylation and in particular dynamic palmitoylation is a regulatory PTM with the ability to modulate interactions and activities.

Many examples of fatty-acylation modulating hydrophobicity, altering interactions and changing
activity are known. These examples extend to the generation of membrane affinity – for example, the catalytic efficiency of signaling cascades is effected by close physical proximity brought
about by membrane-bound clustering – but are much more diverse. In the case of single proteins,
constituitive S-acylation discovered crystallography on auto-palmitoylating Bet3 was shown to
be essential to structure and function by providing internal, stabilizing hydrophobic interactions225. In contrast to a structural role, dynamic palmitoylation regulates protein activity of
GAPDH in response to metabolic state217. Palmitoylation regulates protein-protein interactions
outside effects on membrane association. Such effects have been studied in particular for the
large network of tetraspanins. Abolishion of palmitoylation from integrin β4 diminished associations with tetraspanins CD9, CD81, and CD63, without changing behavior in membrane density
fractionation, lipid raft association or detergent solubility242. Similarly, elimination of palmitoylation in CD151 had minimal influence on density fractionation and detergent solubility but
resulted in significantly less association with CD9 and CD63243. Likewise, palmitoylationdeficient mutants of CD81 show impared interaction with CD9 and EWI-2244. In contrast, palmitoylation of CD9 actually inhibits association with EWI-2 and unmodified proteins are preferentially bound245. Palmitoylation is therefore required for the correct assembly and structure of
the large tetraspanin network often coined the “tetraspanin web”243. While this network is localized to the cell surface, note should be made that palmitoylation does not appear to cause or alter
membrane association. Fatty-acylation status also regulates N-type calcium channel activity
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through modulation of protein-protein interactions. Palmitoylated splice variants of regulatory β
subunits are stimulated by Gq while unmodified forms are inhibited by the same protein246. The
function of palmitoylation thus extends far beyond simple membrane affinity, although this effect remains important. Modification by palmitic acid can modulate protein activity; can modulate intraprotein interactions altering stability and conformation; and can modulate proteinprotein intereactions of quartenary structures by either enhancing or inhibiting binding.

While the tetraspanins represent a very large, if diffuse, complex, the role palmitoylation plays in
spatiotemporal regulation of other large, multi-member and dynamic protein complexes remains
a tantilizing area of future research. Most notable in Figure 19 is the preponderance of such networks and assembelies. Representation is extensive and includes the ribosome, proteasome and
cytoskeleton; metabolic and mitochondrial complexes; and multiple assembelies with DNA and
RNA association such as DNA replication licensing factors and heterogeneous nuclear nibonucleoprotein complexes. Each of these assemblies undergoes dramatic changes depending on cellular state and fatty-acylation likely plays a major role in their dynamic nature. However, the
study of such protein networks and complexes will warrent techniques outside genetic mutation:
the number of proteins and possible sites of modification combine exponentially to make a brute
force approach of this strategy intractable. Further investigation will also likely reveal multiple
roles for activity regulation by fatty-acylation as has been shown for GAPDH. Given the intimate
connection between fatty-acids and key metabolic intermediates, as well as the presence of many
glyclytic enzymes in this and other datasets (see Figure 11, Figure 14 and Figure 19), palmitoylation probably also regulates the activity of multiple metabolic enzyme. Overall, fattyacylation and palmitoylation will increasingly be shown to have major roles in intra- and intre111

protein interactions, and in control of catalytic activity, particularly in the regulation of metabolism.

Histone H3 fatty-acylation
The discovery of S-fatty-acylation on histone H3 variants represents a new type of histone modification whose implications will require further study. In particular, mechanism of fatty-acylation
(Figure 21), dynamics, stability and overall function remain open questions. Cys110 of H3 variants lies buried deep within the nucleosome at the end of the H3 α-2 helix, occupying the center
of a four-helix bundle at the H3-H3’ interface between the two H3-H4 dimers of the (H3-H4)2 tetramer. Through hydrophobic interactions and hydrogen bonds, this region alone causes tetramer
formation247-250. Disrupting the hydrophobic surfaces with a C110E mutation results in obligatory H3-H4 dimers251. Without denaturation, C110 is chemically inaccessible to a wide variety of
sulfhydryl reactive reagents conditions252-255. The involvement of this residue in chromatin structure has been long discussed in the context of an H3-H3 disulfide256,257. However, four separate
crystallographic studies, including one under oxidative conditions, have shown intersulfur distances in assembled nucleosomes to be incompatible with a disulfide linkage247-250. Indeed, this
residue has been shown to become chemically accessible only during active gene transcription258260

. Additionally, in HPLC histone purifications, small quantities of hydrophobic (late-eluting)

species are observed after the main H3 peak261, possibly representing the presence of fattyacylated H3 species.

Cytosolic H3 modification including acetylation or methylation by early acting enzymes prior to
chromatin incorporation has been demonstrated262,263 and given the ER and perinuclear localiza112

tion of multiple DHHC-PATs264, it is possible H3 variants are modified before nuclear incorporation, during nuclear breakdown or possibly at the periphery of the nucleus during specific regulatory events (Figure 27). The lack of chain length dependence (Figure 11 and Figure 12) could
be reflective of the broad substrate specificity of DHHC-PATs.
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Figure 27 Possible roles of histone H3 acylation. The function of histone H3 acylation remains
to be determined and for heterochromatin, might be involved in direct tethering to the nuclear
envelope or tethering through a new protein-protein interaction. If involved in euchromatin, H3
acylation might play a role in a new protein-protein interaction. The dynamics, mechanism and
cellular location of modification remain to be determined.
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Functionally, the S-fatty-acylation of histone H3 variants might, like methylation and acetylation265, alter nuclear events by establishing a binding platform for effector proteins like histone
chaperones (Figure 27). Alternatively, S-palmitoylation could affect the properties of chromatin
itself, perhaps resulting in new, stabilizing hydrophobic interactions within one or between several nucleosomes, or nucleosomes and other chromatin proteins. Palmitoylation might also play a
role in the sub-organellular structure of the nucleus including spatial and functional compartmentalization of proteinaceous nuclear bodies, and chromatin domains and territories266,267. PTMs including methylation and acetylation show distinct nuclear localization, which can change with
tissue type, cellular state and cell cycle268. Such PTMs are well established to modulate gene activity by changing higher-order nuclear organization. For example, the addition of active chromatin marks like H3K9 acetylation or H3K4me2 results in chromatin decondensation and the
formation of chromatin loops269. Whether S-palmitoylation is involved in the regulatory proteinprotein interactions of subnuclear organization remains to be seen. Particularly tempting is the
potential involvement of S-palmitoylation in perinuclear tethering of chromatin to the nuclear
envelope (Figure 27), a localization generally associated with inactive heterochromatin and gene
silencing266,267. Indeed, H3 variants are enriched in the nuclear shell fraction of HeLa cells270.
While such localization might involve interaction with the nuclear membranes, it also could be
protein specific. H3 has been shown to interact with membrane-bound lamin B-receptor
(LBR)271 and BAF (barrier-to-autointegration factor)272, which in turn bind multiple inner nuclear membrane proteins273,274. In addition, carboxyl-terminal tails of nuclear lamins bind H3275.
Given the dynamic nature of S-palmitoylation20, it will be interesting to determine the status of
C110 palmitoylation (and potentially H3.1 C96) in conjunction with other PTMs, through the
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cell cycle and under various states, as well as the relative levels of modification between the H3
variants and their localizations.

Conclusion
Deciphering the function, regulation and meaning of protein fatty-acylation will be an exciting
field for years to come. This survey of proteins and others demonstrate that many more cellular
proteins are modified with fatty acids than previously appreciated. Using fully solubilized mammalian cells, we discovered S-acylation of histone H3 variants. The highly conserved Cys110
was determined by site-directed mutagenesis to be the site of modification for H3.2; the function
of this PTM remains to be elucidated and may be involved in perinuclear chromatin silencing.
The large-scale identification of fatty-acylation sites on proteins remains a significant challenge
and will be essential for dissecting the functional roles of protein fatty-acylation in various cellular pathways. The characterization of specific acyltransferases and lipases responsible for individual fatty-acylated proteins will be key to determining their functions.
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DIRECT VISUALIZATION OF CHOLESTEROL

Introduction
In humans and other vertebrates, cholesterol is essential to life and plays a critical role in disease
and healthy physiology276. Eukaryotic cells have complex mechanisms to sense cholesterol levels
and regulate its synthesis and trafficking277. Defects in cholesterol homeostasis are responsible
for diseases such as familial hypercholesterolemia or atherosclerosis278, and neurological conditions like Niemann-Pick disease276; low brain cholesterol is also associated with autism spectrum
disorders279. Within membranes, cholesterol regulates permeability, fluidity and mechanical
strength, and it is a major component of detergent-resistant microdomains (lipid-rafts)276,280,281.
Cholesterol content in membranes affects protein sorting and activity of membrane proteins276,280,281. Cholesterol is a ligand for some proteins and many of its derivatives are signaling
molecules (e.g. steroid hormones). The major lipid component of the brain is cholesterol, especially in myelin, where it functions as an insulator and enables the efficient transmission of action potential signals282. Cholesterol is a post translational modification (PTM) on the C-terminus
of sonic hedgehog (Shh), where it restricts the spatial diffusion of the morphogen to generate the
gradients that control vertebrate development in tissues27. Cholesterylation defective mutants of
Shh show gross mispatterning and embryonic lethality27. Cholesterol sensing, trafficking and
protein modification are critical to physiology and disease yet their underlying mechanisms are
not fully understood.
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Several techniques have been developed to investigate cholesterol and all have limitations42,79.
Radioactive cholesterol is the most faithful reporter but is limited by speed of detection and cannot be easily combined with other analyses such as immunohistochemistry (IHC). Indirect methods to detect cholesterol include enzymatic assays (cholesterol oxidase), cholesterol-binding proteins (the cholesterol-binding region of perfringolysin O or anti-cholesterol antibodies) and polyene dyes that fluoresce when bound to cholesterol (filipin in particular). These methods can suffer from inaccessibility to cholesterol, giving false negative signal, and may have affinity for
other substances, resulting in false positive signal. Direct visualization methods using fluorescent
cholesterol analogs provide convenient tools to monitor lipid trafficking42,79, but the fusion of
large fluorophores to cholesterol may perturb structural features necessary for its biologically activity (Figure 32) or interfere with specific cholesterol recognition by endogenous mechanisms27,283. The naturally occurring, intrinsically fluorescent sterol dehydroergosterol (DHE)
provides a more faithful fluorescent reporter42,79. However, DHE suffers from low quantum
yield, rapid bleaching and ultra-violet (UV) excitation and emission requiring specialized, UVtransparent imaging equipment42,79. The two-step bioorthogonal method presented here circumvents many of these disadvantages. Cells or animals are labeled with a biologically active cholesterol reporter, 25-azidonorcholesterol (az-chol) (Figure 30), which has minimal structural change
and exhibits similar metabolism and distribution to cholesterol in vivo181,284. Following metabolic
incorporation, az-chol can be reacted with a fluorescent dye best suited to experimental design
via CuI-catalyzed [3+ 2] azide-alkyne cycloaddition (CuAAC)94, often termed “click chemistry”
(Figure 30a). This approach allows the use of standard imaging equipment and is easily combined with common analyses and workflows such as IHC. We show that this bioorthogonal tech-
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nique robustly images from protein cholesterylation to in vivo cholesterol trafficking in cells and
organs.
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Figure 28 Cholesterol, 25-azidonorcholesterol (az-chol) and other cholesterol reporters. Accurate and effective reporting of cholesterol requires an analog to 1) be non-toxic to cells; 2) be incorporated by cells like cholesterol; and 3) have little or no change in biological activity compared to the native molecule. Most analogues perturb the structural features essential to the biological activity of cholesterol (a) including: a free 3 -hydroxyl (highlighted in red), the planar
tetracyclic ring system (brown) including the 5(6) double bond (magenta), angular methyl
groups (green) and the 17 -octyl side chain (pink); modifications to these characteristics can
cause substantially altered behavior; for example 22 and 25 NBD-cholesterol orient themselves
“up-side-down” with the 3 -hydroxyl in the interior of the membrane. (b) 25-azidonorcholesterol (az-chol) maintains all these key features, simply replacing methyl 26 with an azide
(blue). (c) Intrinsically fluorescent cholesterol analogs exhibit similar and nonidentical physiochemical behavior to cholesterol; they retain some of the most faithful biological activity. Both
differ from cholesterol by desaturation of their 7(8), 9(11) and in the case of dehydroergosterol, its 22(23) double bond and an additional methyl group at C24. (d) Spin-labeled 25doxylnorcholesterol exhibits biophysical membrane properties that closely match cholesterol,
demonstrating that the octyl chain can tolerate modification. (e) Many fluorescent cholesterol
analogs exist; all have significantly modified structure from (a). (f) Multiple crosslinking analogs
are available and also exhibit strong structural deviations from (a).
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Az-chol was evaluated as a cholesterol analog for photocrosslinking over three decades ago181,284
and exhibits minimal structural perturbation, as the replacement of a methyl group with an azide maintains the key features80 of biologically active cholesterol (Figure 28). The azide does not
substantially alter size or hydrophobicity, does not add charge and is biologically compatible.
Isotope labeling experiments show that az-chol is incorporated into the membranes of baby hamster kidney 21 (BHK-21) cells in place of cholesterol and is sensed by HMG-CoA (3-hydroxy-3methyl-glutaryl-CoA reductase, the key regulatory enzyme in the cholesterol biosynthetic pathway), and causes inhibition of de novo cholesterol synthesis181,284. Incorporation kinetics of radioactively labeled cholesterol and az-chol are nearly identically from 5 to 25 µg/mL (12 – 60
µM)181. Cells supplemented with cholesterol or az-chol show no significant differences in cell
growth, DNA, RNA or protein synthesis181. Az-chol does not alter cell morphology after application up to 96 hours181. After intravenous injection in rats, az-chol is transported to the liver and,
as cholesterol, distributes to all subcellular fractions284. Az-chol upregulates acylCoA:cholesterol O-acyltransferase activity in vivo and, as in cells, downregulates HMG-CoA284.
Esterified az-chol products were also found in the blood and liver284. Az-chol has thus been
shown to have biological activity very similar to cholesterol in cells and animals.
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Results
Given the biological activity of az-chol284 and usefulness of chemical reporters and bioorthogonal methods to study protein lipidation93,94,285,286 and lipid trafficking86,287, we synthesized azchol181 (Figure 29) and applied it to study cholesterol localization, trafficking and protein modification (Figure 30, Figure 31 ). We began by verifying az-chol incorporation onto Shh, a known
cholesterylated protein27. Cholesterylation of Shh is an autocatalytic processing event of the
45 kDa precursor protein cleaving a 19 kDa N-terminal domain that must also be palmitoylated
for proper activity27. We metabolically labeled human embryonic kidney (HEK) 293T cells that
inducibly overexpress Shh288 (293T-Shh) with az-chol and immunopurified Shh. The isolated
morphogen was then reacted with alkynyl-rhodamine via CuAAC and the modification was imaged by in-gel fluorescence scanning (Figure 30b). Because Shh is N-terminally palmitoylated,
we also labeled 293T-Shh cells with an azido-palmitate reporter (az-15)93,94 as a control for protein labeling. Both az-chol and az-15 were incorporated onto mature Shh, indicating that az-chol
correctly reports protein cholesterylation (Figure 30b). Az-15 labeling and rhodamine modification alone did not introduce a significant mobility shift, while az-chol labeling induced a noticeable increase in the apparent molecular weight of Shh (Figure 30b lanes 1 – 3). Dual metabolic
labeling with az-15 and az-chol imparted a yet further decease in Shh mobility (Figure 30b, lane
4). Notably, we observe other az-chol-modified proteins in total cell lysates (Figure 31 lanes 1 –
2), echoing the original autoradiographic evidence that cholesterol modification exists on proteins other than Shh26,27. Az-chol thus serves as an efficient chemical reporter for protein cholesterylation and we anticipate it will be useful in elucidating the identity and function of modified
proteins.
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Figure 29 Synthesis and characterization of az-chol. (a) Az-chol was synthesized as previously
described with the exception that final product was purified by silica gel chromatography. (b)
Proton NMR.
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Figure 30 25-azidonorcholesterol (az-chol) labeling. (a) Az-chol is first metabolically incorporated in cell culture or in utero. Subsequently, az-chol can be visualized by conjugation to rhodamine through click-chemistry. (b) In-gel fluorescence and Western blot analysis of Shh labeled
with lipids and their clickable analogs. Both az-chol and az-15 were incorporated onto N-Shh
and imparted gel mobility shifts. Modification with rhodamine conjugates of az-15 alone show
the least shift (lane 2, left-hand panel), followed by az-chol (lane 3); their combination imparted
the greatest apparent increase in molecular weight (lane 4). Due to transfer efficiency, a 20% gel
was used for Western blotting which condensed the band bearing both lipid analogs (lane 4,
right-hand panel).
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Figure 31 Shh induction and validation of lipid PTMs. Fluorescence profiles of 293T cells with and without Shh overexpression. 293T cells and
Shh overexpressing cells incorporate az-chol and dominant signal is present at ~19 kDa and upregulated by overexpression; 293T cells lacking
Shh show incorporation onto unknown proteins. Different band shifts are
apparent with each modification or combinations thereof.

We then evaluated az-chol as a reporter for cholesterol distribution in mammalian cells by fluorescence microscopy. For these experiments we used Chinese hamster ovary (CHO) cells and
M12 mutant CHO cells that carry a deletion of the NPC1 locus289. Defects in this gene result in
Niemann-Pick disease type C, an autosomal recessive lipid storage disorder characterized by the
accumulation of cholesterol in enlarged endosomal-lysosomal storage compartments290,291. These
filipin-positive perinuclear organelles have been used in NPC disease diagnosis for years292 and
we sought to compare filipin staining with az-chol imaging. We first verified that application of
az-chol did not alter fine cell morphology of wild-type CHO or M12 cells compared to choles126

terol by electron microscopy (Figure 32). For fluorescence imaging, cells were metabolically labeled with az-chol or cholesterol, fixed (and, in the case of antibody staining, permeabilized with
1% Tween-20), reacted with alkyne-rhodamine via CuAAC, simultaneously co-stained with filipin and imaged by fluorescence microscopy. Az-chol labeled CHO and M12 cells exhibited
bright rhodamine fluorescence in intracellular vesicles and cellular membranes; signal was distributed throughout the cell though attenuated in the nucleus (Figure 33). Rhodamine but not filipin fluorescence was absent in cholesterol-treated samples (Figure 33a and b far right; Figure
34a). Staining patterns for az-chol and filipin were similar and distinct (Figure 33). Fluorescence
overlap was extensive (Pearson’s coefficient 0.5 – 0.7), particularly in the cholesterol storage organelles of M12 cells, but some filipin positive regions (organelles or lipid droplets) showed no
az-chol signal; the opposite was also true (Figure 33a and b inserts). Particularly notable was labeling in the vicinity of the cell membrane: although both techniques labeled the cell membrane,
az-chol tended to outline filipin staining (Figure 33a and b, arrowheads).
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Figure 32 Electron microscopy analysis of CHO cells reveals no morphological changes. CHO
cells (a) and M12 cells (b) show no difference in gross or fine morphology when cultured with
either cholesterol (top rows) or az-chol (bottom rows) as determined by EM. Note the prominent,
enlarged endosomal-lysosomal lipid storage organelles in (b).
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Figure 33 Az-chol and filipin labeling of normal and Niemann Pick type C disease model cells
with and without MβCD cholesterol depletion. False-color representation of (a) normal CHO
NPC+/+ and (b) CHO M12 NPC-/- cells. Scale bars are 10 µm (main), 2.5 µm (insert). Overlap
between filipin and az-chol signal is substantial yet different. Some regions are filipin positive
and az-chol negative; the reverse is also true (a, b). Az-chol signal tended to outline filipin staining of the plasma membrane (insert arrowheads). Az-chol and filipin both localize to M12 cholesterol-rich lipid droplets but show distinct localization (b). MβCD cholesterol depletion virtually eliminates az-chol signal but leaves filipin signal for both cells and lipid-rich structures (a, b);
cholesterol controls show no az-chol labeling (a, b and Figure 34a) and all signal from either
technique is abrogated with methanol lipid extraction (Figure 34). (c) NPC cholesterol and lipid
storage compartments are generally encircled by LAMP-1 signal.

130

131

To shed light on the differences between az-chol and filipin staining, we evaluated both imaging
techniques after lipid extraction and also examined colocalization with subcellular markers. As
expected, az-chol signal was almost entirely abrogated by cholesterol extraction with methyl-βcyclodextran (MβCD) (Figure 33a and b). This contrasted with filipin, where signal remained for
some CHO cells and many M12 cells, particularly in their lipid storage compartments (Figure
33a, b). In contrast, general lipid extraction with methanol completely eliminated fluorescence
staining for both methods (Figure 34b). We examined the subcellular distribution of az-chol and
filipin with markers for ER (calreticulin), Golgi apparatus (Golgin 97), early endosomes (EEA1),
lysosomes (LAMP-1) and GM1-gangliosides often found in lipid rafts (cholera toxin B). As previously reported293, az-chol and filipin stained lysosomal storage compartments encircled by
LAMP-1 positive vacuolar membranes; these compartments are significantly more pronounced
in M12 cells compared to wild type (Figure 33c and Figure 35). Notably, multiple compartments
could be seen with an az-chol rich core surrounded by a filipin positive layer and outlined by
LAMP-1 signal (Figure 33, insert arrowheads). Az-chol and filipin colocalization with GM1ganglioside staining was pronounced in M12 storage compartments (Figure 36), as previously
observed294. We found minimal az-chol colocalization with other subcellular markers (Pearson’s
coefficients 0.0 – 0.3), probably reflective of the broad distribution of cholesterol throughout cellular organelles, and az-chol did not appear to alter the localization of subcellular markers (Figs.
S7 – S9 ). Az-chol thus enables imaging of cholesterol distribution in cells similar to filipin and
filipin also stains methanol soluble, MβCD-resistant lipids.
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Figure 34 Absence of az-chol signal with cholesterol and elimination of lipid staining with
methanol lipid extraction. (a) For CHO or M12 cells cultured with cholesterol, background
staining was minimal and filipin staining unchanged. (b) Lipid extraction with methanol eliminated all signal for both az-chol and filipin. Cell presence was verified by SYTO 11 staining.
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Figure 35 LAMP-1 signal encircles small late endosomal/lysosomal organelles in CHO cells (a)
and much larger cholesterol storage compartments in M12 cells (b). Cholesterol controls show
no rhodamine signal.
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Figure 36 GM1-ganglioside binding FITC-cholera toxin B shows little signal and no pronounced
colocalization with az-chol in CHO cells (a). Az-chol, filipin and cholera toxin staining was pronounced in the cholesterol storage organelles of M12 cells (b).

135

Figure 37 ER marker calreticulin shows no pronounced colocalization with Az-chol in CHO (a)
or M12 cells (b).
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Figure 38 Early endosome marker EEA1 shows no pronounced colocalization with Az-chol in
CHO (a) or M12 cells (b).
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Figure 39 Golgi marker Golgin 97 shows no pronounced colocalization with Az-chol in CHO
(a) or M12 cells (b).
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We then explored the utility of az-chol for imaging cholesterol distribution in vivo. With only
~2% of body weight yet nearly a quarter of total cholesterol, the brain is the most cholesterol rich
organ282. Defects in brain cholesterol homeostasis have dramatic consequences from development on and often involve the Purkinje cells of the cerebellum: a hallmark of NPC disease is
Purkinje cell degeneration282,289 and cerebellar hypoplasia is observed in Smith Lemli-Opitz syndrome that results from a defect in the last step of cholesterol synthesis295. Purkinje cells are also
a major site of neurosteroid synthesis296 and brain cholesterol turnover via cholesterol 24hydroxylase282. We thus imaged cholesterol distribution in the cerebellum of a developing mouse
embryo. Because maternal cholesterol is poorly absorbed and cholesterol is excluded by the
blood-brain-barrier282, az-chol was directly injected into the lateral ventricle of an E12.5 mouse
embryo. Sagittal sections at low and high magnification revealed an asymmetrical cholesterol
distribution (Figure 40). At low magnification, nascent neurons were more intensely labeled,
likely a reflection of high cholesterol content (Figure 40a, magenta arrowheads). This trend continued in the inferior colliculus where cells with neural morphology displayed prominent az-chol
labeling (Figure 40a, labeled IC, magenta arrowheads). In addition, the apical surfaces of the
cerebellum and inferior colliculus appeared to be enclosed by a cholesterol-rich envelope; the pial surface of the inferior colliculus displayed the same layer (Figure 40a and inserts, white arrowheads). Higher magnification revealed distinct plasma membrane az-chol labeling as well as
cell polarization with az-chol enriched toward the apical surface (Figure 40b and inserts, magenta arrows); this pattern continued throughout the layers of the pseudostratified neuroepithelium.
The thick az-chol–rich layer at the apical surface of the cerebellum was pronounced under high
magnification (Figure 40b and inserts, white arrows). This could be reflective of a “sealant”
membrane providing proper containment of cerebrospinal fluid (CSF) and might be composed
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either of polarized surface cells or an extracellular deposition. Alternatively, the cholesterol-rich
layer could provide a binding platform for lipophilic hormones and factors circulating in CSF.
Az-chol is thus useful for in vivo imaging of cholesterol distribution in embryos and organs.
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Figure 40 Cholesterol localization in the developing mouse brain. Cholesterol was asymmetrically distributed in the cerebellum (C) and inferior colliculus (IC) of the E12.5 developing
mouse brain. Scale bars are 50 µm (main), 25 µm (insert). (a) Under low magnification, an azchol–rich envelope (white arrowheads) surrounded the apical surface (AS) of the cerebellum and
inferior colliculus. These apical surfaces interface the cerebrospinal fluid (CSF) filled ventricles
(V). The pial surface (PS) of the inferior colliculus also exhibited an exterior az-chol band. Azchol signal was pronounced in nascent neurons (magenta arrowheads; see also inserts), likely reflecting high cholesterol content. Rhodamine signal was absent in littermate controls. (b) Higher
resolution revealed the structure of the thick apical envelope in the cerebellum (white arrowheads). Scale bars are 10 µm (main), 2.5 µm (insert). Az-chol distinctly labeled plasma membranes of neural progenitors and tended to show apical localization (magenta arrowheads). Apical polarization of az-chol signal was observed many cells deep into the neuroepithelium.
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Discussion
Cholesterol has long been difficult to image. External factors other than cholesterol can alter the
results of indirect assays: cholesterol oxidase results depend on membrane composition and location, fixing technique and a host of other aspects79,297. Likewise, perfringolysin O derivatives only bind regions with high (>20-25 mol%) cholesterol content and may be influenced by membrane properties79. Echoing the results here, filipin has been previously reported to yield false
positive signal after cholesterol predepletion with MβCDs and can report the opposite of perfringolysin O staining79. Filipin false negatives have also been observed for multiple organelles297,
depending on clathrin content298, and in smooth muscle plasma membrane299. The persistence of
filipin signal after MβCD but not methanol for normal and M12 cells (above and Figure 34) indicates filipin has substantial lipid affinities outside of cholesterol.

Direct imaging of cholesterol has also presented challenges. All but a few cholesterol analogs
have significant structural changes that perturb key features essential to the biologically activity
of cholesterol42,71,79 (above). Some of these changes radically alter cholesterol behavior, resulting
in an “upside down” orientation (with the free 3 -hydroxyl pointing into the membrane interior)
or disrupting cholesterol-induced phospholipid membrane condensation42,68. Intrinsically fluorescent sterols like DHE and cholestatrienol, despite their similarity in biological behavior, are
limited by their requirement of UV compatible instrumentation and may face a high background
from tissue autofluorescence. The two-step labeling approach described here involves the metabolic incorporation of a biologically active cholesterol reporter, az-chol, which has minimal
structural perturbation compared to cholesterol, traffics like it and is nontoxic in vivo. Subsequently, fluorescent dyes are installed using bioorthogonal ligation methods for direct imaging.
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This approach can be applied from a single protein to a whole organism and represents an excellent option for rapid, easily accessible and multimodal cholesterol imaging. We anticipate
bioorthogonal cholesterol reporters like az-chol will aid in the study of cholesterol function in
physiology and disease.
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FUTURE DIRECTIONS
The identification of a new class of histone PTMs raises many interesting questions about biological significance including the mechanism of modification, stability, dynamics and regulation,
effect on structure and chromatin stability, as well as effect on histone localization. These questions represent exciting possibilities for future experimental work.

Validation of in-vivo modification
As illustrated in Figure 21, of the three potential mechanisms for fatty-acylation of histone H3,
the possibility of in vivo chemical modification is unlikely due to the low concentration of activated fatty acids resulting from acyl-carrier binding proteins (ACBPs). In addition, the chemical
inaccessibility of intact histones precludes reaction. However, there exists the chance that acylation occurs as a post-lysis artifact, when both ACBPs and nucleosomes are denatured exposing
both the formerly unreactive cysteine and releasing activated CoA esters. Thus, this possibility
should be examined prior to other research.

Validation of in-vivo modification by manipulation of activated CoA and sulfhydryl reactivity
Two straightforward experiments can quickly answer this answer. In the first approach, the reaction between endogenous activated fatty-acid ester and free thiols is chemically modified. After
metabolic labeling with alkyne or azido palmitic acid, cells can be split into three equal fractions.
One fraction will be subject to rapid lysis (Polytron) in the presence of a large excess (e.g.100
mM) of a reduced thiol such as mercaptoethanol or cysteamine, providing a sink for activated
fatty acids. As the total cellular concentration of activated acyl-CoA esters lies in the range of 5 –
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160 µM 300, this 600 – 20,000-fold excess will substantially reduce if not prevent post-lysis fattyacylation. The second fraction will be likewise lysed in an excess of a thiol capping reagent, such
as iodoacetamide, also in high concentration (e.g. 50 mM). Under such conditions, newly exposed thiols are likely to be immediately capped, rather than potentially acylated. The third fraction serves as a control and can be lysed without change from previous experiments. After lysis,
thiol, thiol capping reagent and any remaining CoA intermediates will be removed by simple
methanol precipitation; previous experiments indicate click chemistry is unaffected after either
thiol capping or after reduction with mercaptoethanol, as long as such reagents are removed by
precipitation. Following protein pellet resuspension and the addition of cleavable affinity tag, the
capture and retrieval can be repeated as previously. Parallel Western blot analysis will reveal if
histone H3 fatty-acylation is reduced or eliminated by excess free thiol or thiol capping compared to control levels. This approach offers the advantage that cellular concentrations of both
small molecules (excepting added reagents) and proteins remain unmodified. Both thiol capping
and a thiol sink represent a mechanism to control post-lysis fatty-acylation, should it be occurring.

Validation by addition of marked activated CoA-palmitate
Mirroring this approach but monitoring the presence rather than lack of reaction, a potential
chemical modification can be determined by the inclusion of a marked activated fatty acid, either
radioactive or stable isotope, or the addition of a marked protein, either bearing a tag or likewise
isotopically marked, which is present during lysis. In the first case, [13C]-palmitic acid available
from multiple suppliers can be activated as described

301

and added at physiologically relevant

concentrations (e.g. 5, 50 and 100 µM) to cells during histone extraction lysis. Isolated histones
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can then be dually digested sequentially with trypsin and GluC, which will produce a peptide
TNLCAIHAK of monoisotopic mass 969.507 when unmodified. This size is well within the
range of MS peptide analysis. The relatively uncomplicated protein composition of a histone extraction allows infusion and monitoring of a particular m/z, circumventing the possibility that
lipidated peptides are lost on a reverse phase column. Alternatively, a different stationary phase
such as a HILIC (hydrophilic interaction liquid chromatography) column which elutes similar to
a normal phase could be employed. In either case, the m/z of the peptide alone, likely as a doubly
charged species, and the peptide modified by palmitic acid, palmitic acid analogs, or isotopically
tagged palmitic acid can be followed. The reaction of added activated esters resulting in [13C]palmitoylated histone peptides suggests a post-lysis artifact. However, to properly interpret results, this experimental setup requires exact knowledge of the concentration of endogenous activated esters as the two and a half log variation in concentration will substantially change extent
of reaction: observation of a newly modified species at 100 µM might not reflect the mechanism
of palmitoylation if endogenous concentrations are 10 µM or less.

Validation by addition of marked H3
Because exact endogenous concentration of activated fatty acids may be difficult to ascertain, a
more straightforward approach is the addition of tagged histone H3 during lysis. This tag can be
genetic, such as the his-tagged H3 variants employed here, or it could be marked by stable isotope labeling. The most interpretable data would be generated by addition of a purified histone
and the myc-his-tagged H3 variants employed here provides a convenient mechanism of purification (IMAC). Alternatively, an isotopically marked H3 could be purified by histone extraction
and immunoprecipitation (Figure 13). Whole cell lysates from co-lysis of cell pellets of either
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genetically or isotopically marked, together with cells metabolically labeled with clickable precursors, represents another possible approach. However, in this case the levels of small molecule
are uncertain, and competing, possibly differentially labeled, activated fatty acid esters could
complicate results. While concentrations could be assumed to be equivalent in cells cultured
simultaneously, e.g. with the same concentration of [13C]-lysine and [12C]-lysine, the fact that alkyne-fatty acids in particular modify fatty acid metabolism makes this assumption precarious.
Additionally, for genetically tagged, overexpressed H3, the relative protein concentrations will
be unknown and are likely difficult to control.

In all configurations, the lysis buffer would contain a known quantity of histone, preferably
matched to endogenous levels (equalize by Western blotting). After a native, non-reducing gel to
check that the cysteine is still free (no H3 dimers), the purified protein would be dissolved in the
same volume of lysis buffer and the cells lysed with this solution as before. The check for disulfide status could also be done on purified proteins via a colorimetric assay (Ellman’s reagent) but
is essential to ensure free sulfhydryls due to the lack of disulfide reactivity. Alternatively, the
same number of metabolically labeled wild-type cells and genetically tagged, H3-expressing
cells could be copelleted and lysed. Analysis can be by Western, looking for H3 itself (which in
the myc-his-H3 is shifted by the myc-his tag), by an antibody against the myc epitope or by both
antibodies, simultaneously, sequentially or in two membrane stripes. In the case of myc-his-H3s
used here, after purification of palmitoylated proteins as described from native cells lysed in the
presence of myc-his-H3s, the presence of a myc tag from clickable fatty acid analogs indicates
post-lysis reaction has occurred.
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A final experimental setup would examine the presence of newly (chemically) palmitoylated,
isotopically marked peptides. In this arrangement, lysis by histone extraction would take place
with simultaneous inclusion of purified isotopically marked histone H3, for example labeled with
[13C]-cysteine, again in a roughly equivalent concentration to endogenous levels). Chemically
modified, isotopically marked peptides can then be detected after codigestion with trypsin and
GluC as described above. For all cases in which histone extraction is used, it must be noted that
HPLC separations of histones are well established. Thus, after knowing the chromatographic
properties of a palmitoylated standard, HPLC can allow for both enrichment as well as detection.
Such a standard can be made by incubating reduced, purified H3 with a large concentration of
CoA-palmitate (e.g. 0.1 – 1 mM) using e.g. methyl-beta-cyclodextrin and/or organics to maintain
solubility; the established HPLC separation methods allow purification for additional experimental investigation described below.

Future experimental analysis of palmitoylated H3
After verification that histone modification is not an artifact of post-lysis chemical reaction, experiments can address the possible influences of fatty-acylation on nuclear location; dynamics
and regulation of histone palmitoylation throughout the cell cycle and relationship to other histone PTMs; mechanism of modification; effect on nucleosome stability; effect on nucleosome
structure; and the possibility of palmitoylated H3 selectively preferring particular DNA sequences.
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Subnuclear localization
The effect of palmitoylation on subnuclear localization can be easily addressed in two experimental approaches. First, immunohistochemical techniques employing an anti-myc antibody can
examine the localization of myc-his tagged H3 and the tagged C→A mutant. Various cell lines
can be transfected as described, protein allowed to be expressed for e.g. 12 hours, fixed, permeabilized, and visualized with anti-myc antibody. Predigestion with a nuclease (e.g. Benzonase)
may be required for optimal signal and neighboring untransfected cells serve as negative controls. This approach, while direct, may suffer from limited selectivity due to the low stoichiometry of modification. To combat this limitation, as nucleosomal histones have been shown to
translocate across cell membranes into the nucleus302, exogenously supplied H3 – both fully
palmitoylated and reduced – can be applied externally. Nuclear trafficking of purified, epitopelabeled histone H3 can be imaged by IHC. Alternatively, the fatty-acylated and unmodified H3
can be marked with a fluorophore by either genetic means (e.g. GFP) or chemical reaction (e.g.
dansyl chloride, sulfo-NHS-rhodamine) and imaged during and after incorporation. This approach allows live imaging but the behavior of the modified histone must be validated by comparison to a less perturbed system. One of the best approaches for a validation would be application of an H3 variant palmitoylated in vitro with a clickable analog to cells grown otherwise
without clickable analogs. Visualization with the click reaction in combination with subcellular
markers would then reveal localization, such as preferential association with the nuclear envelope. Ideally, this technique will also be combined with analysis of cell cycle as described below.
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Cell cycle dynamics of H3 palmitoylation and palmitoylation relationship to other histone PTMs
Many histone PTMs vary throughout the cell cycle and this may also be the case for histone H3
palmitoylation. The possibility can be easily examined through a combination of cell synchronization and metabolic labeling; by analyzing both state of protein modification and cellular localization, insight can be gleaned as to the possible cycle-dependent effects of palmitoylation on
protein trafficking. Analysis of time points selected to fall within each point of the cell cycle
should be performed after double thymidine block, thymidine-nocodazole block or serum starvation. In each case, cells can be metabolically labeled with alkyne or azido fatty acids for a constant incubation of 1-12 hrs, likely optimally at 4-6 hrs, before the sample is lysed. Samples can
then be parallel purified for fatty-acylated proteins and analyzed by Western blotting. Alternatively, purified samples may be analyzed by mass spectrometry after digestion with various
combinations of proteases both for relative abundance and information of PTMs present on palmitoylated histone peptides. This could be done in a label-free manner, but would be best performed by protein level labeling with iTRAQ. Following iTRAQ labeling, samples of various
time points can be combined and purified in a single purification. Labeled proteins can subsequently be digested and analyzed in one run, eliminating sample preparation variability, and
mass spectrometric analysis would yield information of both the relative abundance and identity
of accompanying, possibly varying PTMs throughout the cell cycle. The analysis of co-occurring
PTMs is of course also possible without cell synchronization, however it makes the most sense in
that context. Antibodies to various histone PTMs and Western blotting of purified palmitoylated
proteins represent an alternative method to detect combinations of PTMs linked to histone palmitoylation. For both detections, dynamics would be reflected by a change in relative palmitoylated abundance throughout various time points in the cell cycle. In order to properly inter151

pret the results, a required control is knowledge of total H3 levels; this can be obtained by a
Western of input material before fractionation or likewise analysis by MS and iTRAQ signal after digestion.

Mechanism of modification
After ruling out chemical modification during lysis, the remaining possibilities of autocatalytic
modification and enzyme-mediated fatty-acylation can be tested with two simple experiments.
While autocatalytic modification is unlikely, a consequence of the known buried and unreactive
state of H3 sulfhydryl in assembled nucleosomes, it cannot be ruled out a priori: automodification might for example occur in rout to the nucleus prior to quaternary structure. To experimentally address this possibility, purified H3 (IMAC purification for his-tagged H3 variants,
immunoprecipitation or HPLC from native sources, or a combination of these strategies) can be
incubated with activated palmitoyl-CoA esters of either radiolabeled or clickable fatty acids in
the presence and absence of acyl-carrier binding protein. In the former case, detection is by autoradiography and in the latter, in-gel fluorescence after click chemistry with a fluorophore. In the
absence of ACBP, reaction at high (e.g. mM levels) of activated ester is expected; such levels are
unreflective of cellular condition, reflect simple chemical modification and serve as a positive
control. Note that solubility in the absence of ACBP may be an issue and may require the presence of MBCD. Self-palmitoylation such as the loading step of DHHC-PATs takes place in the
presence of fatty-acid binding proteins and palmitoylation of H3 in the presence of ACBP at reasonable concentration (e.g. 5 – 250 µM) suggests autocatalytic modification. In this case, further
studies of enzyme kinetics are warranted. For both autocatalytic and enzyme-mediated modification, the C→A mutant generated in this work should be included as a negative control.
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If autocatalytic modification is absent, enzymatic modification by DHHC-PATs can be assayed
by the co-overexpression of H3 variants with DHHC-PATs (in pools or individually); an empty
vector transfection serves as a negative control. Detection is as above, either click chemistry and
subsequent in-gel fluorescence or autoradiography, both after metabolic incorporation of respective analogs. The simplest readout is an SDS-PAGE gel looking for a H3 signal noticeably upregulated by the cotransfection of one or more PATs. Alternatively, a more precise result can be
obtained by isolation of fatty-acylated proteins, followed by Western detection as described. In
the case, the same anti-myc can be used for detection, or as described above, alternatively the anti-H3 antibody looking either for the shifted histone signal, or the endogenous signal, which in
the presence of an active DHHC-PAT would also be expected to increase in abundance. The possible identification of a PAT modification of H3 begs additional questions such as the location of
modification and its timing, questions which would be addressed by experiments.

Effect of H3 palmitoylation on nucleosome composition and stability
H3 palmitoylation might modify the stability of histone octamers, possibly strikingly: as the buried cysteines already form a region of hydrophobic yet reversible259,260 hydrophobic interaction,
palmitoylation of one or both H3 cysteines could foster an especially stable interaction, as has
been observed in and which is required for activity of Bet3303,304. This interaction could be between two palmitate residues, or alternatively between a native and modified H3. Experimental
analysis of these questions requires purification of H3 and other core histones, which is most easily done in an appropriate scale by HPLC261 from cell lines or native sources. Chicken erythrocytes have historically been heavily employed and protocols employing that protein source have
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been developed for nucleosome reconstitution305 and crystallization247. In addition, because a
C→A mutant can be generated in vitro by Raney nickel dethiolation of cysteine306, this likely
represents the best material for biochemical experiments.

After purification of core histones from chicken erythrocytes, dethiolation of a portion of H3,
palmitoylation of another portion of H3 as described above under “Validation by addition of
marked H3,” and validation of identity, purity and extent of reaction (SDS-PAGE and mass spectrometry or Western blotting or both), core histones can be reconstituted by established methods
305

. Histone octamer reconstitution can be validated by gel filtration chromatography, analytical

centrifugation and native non-reducing gels. Reconstitution of the nucleosomes with palmitoylated H3 may require experimental optimization such as alterations in chaotrope (thiourea
or guanidinium chloride might for example be substituted for urea), changes in dialysis such as
times, chaotrope concentrations, temperatures or chaotrope substitutions; these experimental
modifications must be empirically determined.

Reconstitutions should be attempted with native, fully palmitoylated and dethiolated H3. In addition, a reconstitution should be performed with an equimolar mix of palmitoylated and native or
dethiolated H3 to addresses the preference of acylated H3 within the environment of the nucleosome. To determine this preference, nucleosome subunits should be fully chemically crosslinked307, the different variations of nucleosome composition isolated by HPLC and the sulfhydryl content of fractions determined (e.g. Ellman’s reagent). While a somewhat heterogeneous
set of products is expected due to crosslinking, a predominant fraction with one free cysteine per
262 kDa nucleosome reflects preference of a palmitoylated H3 for native H3. In conjunction
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with this approach, H3 modified with a clickable palmitic acid analog can be reacted with a
fluorophore and the molar equivalent of fatty acid per fraction determined by absorbance or fluorescence; specific radioactivity can be employed in an analogous manner.

Octamer stability of reconstitutions from native, dethiolated and fatty-acylated octamer can most
easy be compared by non-reducing urea gradient gels; this provides a direct, side-by-side comparison of dissociations. Alternatively, analytical ultracentrifugation of octamer with different
concentrations of chaotrope or salt can determine the relative equilibrium of subunit and assembled nucleosome. Finally, reconstituted octamers can be combined with DNA308 and the resulting
pellet exposed to gradually increasing salt concentrations309. Decreased stability results in the increased release of histone monomers into the supernatant at lower salt concentrations (gel).

Effect of H3 palmitoylation on chromatin and nucleosome structure
The possibly different chromatin structure resulting different states of H3 acylation in nucleosomes can be explored by many techniques such as digestion, gel-shift and supercoiling assays.
However, such reconstitution is subject to influence by a wide variety of variables including
DNA:histone ratio, possibly ATP-dependent assembly machinery and others310. These parameters must be empirically explored. At the single nucleosome level, established crystallization
conditions can be attempted after successful reconstitution in either the presence or absence of
DNA; the addition of one or two palmitates could however result in substantially changed crystallization conditions.
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Palmitoylated H3 protein and DNA sequence selectively
In addition to possible effects that altered nucleosome structure could have overall on chromatin,
H3 palmitoylation might affect the proteins which bind octamers. Changes in both preferred protein binding partner and sequence can be determined by combining metabolic labeling and purification of lipidated proteins with a myc-his tagged H3. Both analyses begin as described for the
identification of palmitoylated H3 with overexpression and simultaneous metabolic labeling. A
modified chromatin IP (ChIP) is employed for identification of DNA binding sites in which cells
are fixed in formaldehyde, nuclei are isolated and disrupted followed by micrococcal nuclease
digestion to nucleosomes311. These crosslinked nucleosome are subjected under denaturing conditions (urea and/or SDS) to serial isolation of the his-tag (IMAC) followed by capture of palmitoylated proteins as described. The flow through must be examined to determine the absence
of biotinylated, palmitoylated proteins for the accurate comparison of differences in binding sequence of H3 modification. Both unmodified H3 proteins of the flow-through and the Na2S2O4
eluted, palmitoylated H3 can be matched in protein concentration and subjected to protease K
digestion. DNA is then extracted (chloroform/methanol), gel purified and sequenced to reveal
differences in DNA sequence preference311.

Proteins interacting with H3 of different states of fatty-acylation can be determined in an analogous manner but leaving protein not DNA. In this case, chromatin is prepared as above but crosslinked with a cleavable crosslinker such as BSOCOES (base cleavable), DSP, DTSSP or DTBP
(thiol cleavable; see caution below), or DST (periodate cleavable) in place of formaldehyde. After denaturation (SDS/urea), benzonase is used to fully digest DNA. IMAC under denaturing
conditions can then isolate his-tagged H3 and palmitoylated H3 is subsequently purified on
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beads as described but not eluted with Na2S2O4. Rather, the release agent for the cleavable crosslinker is applied, releasing proteins bound to palmitoylated H3. Similarly, the flow through from
fatty-acylated H3 purification can be re-applied to another IMAC column and the bound, crosslinked proteins released by the necessary cleaving reagent. Note that while sodium dithionite is
reasonably tolerant to sulfhydryls (analysis of labeled proteins by reducing SDS-PAGE is possible), storage of samples in BME, even at – 80 C, resulted in loss of signal, indicating that elution
with thiol will require optimization of time and concentration on model systems. Likewise,
IMAC is sensitive to pH and the redox state of nickel; conditions will require optimization. The
eluted H3 crosslinked fractions can then be analyzed by mass spectrometry (in-gel or insolution).

Analysis of in-vivo effect
After H3 palmitoylation has been verified to take place in vivo and studied in vitro, the modification can be studied in vivo in mice. This will involve either kockin of H3.1, H3.2 and H3.3 each
bearing C→A mutations, followed by subsequent crossing, or kockout of two of the three followed by crosslink with the remaining mutant. According to the Mouse Genome Database, no
knockouts exist for any H3 variant, and the first experiment would involve determination of viability for knockouts of H3 variants.
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CONCLUSION
Like science upon which they are based, these new techniques represent stepping stones and the
most interesting work lies ahead: what is the function of histone palmitoylation and what else is
ubiquitous, ancient, essential yet potentially harmful cholesterol doing? Many histone PTMs
have no phenotype; would this one? Here at Rockefeller the Allfrey lab discovered this buried
histone residue to be opened up during active transcription260. Could palmitoylation serve to anchor necessary protein complexes – more or less the major role lipids serve on proteins – during
this process? Likewise, this work discovered many ribosomal proteins to be lipidated, work later
validated by the Freeman lab, and revealed fatty-acylation of may multi-protein complexes.
What else have we been missing in the role of lipids to organize cellular processes? It will be exciting to see what biology falls out of unbiased screens such as this one, and this study is another
stark reminder of how much sample preparation influences results. Lipids and in particular cholesterol seem to be prominently involved in factors essential to the development of organisms
and to me, they have always seemed to be a sort of a “gentle anchor”; this is particularly apparent in Shh distribution of cholesterylation null mutants. With the ability to visualize the presence
and distributions of lipidated proteins, the door opens to the study of such low-level factors (as
has already started99), allowing us to finally decipher why so many secreted factors are lipidated.
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